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ABSTRACT 
 
Docosahexaenoic Acid Differentially Modulates Plasma Membrane Targeting and 
Subcellular Localization of Lipidated Proteins in Colonocytes. (December 2004) 
Jeongmin Seo, B.S., Seoul National University; M.S., Seoul National University 
Chair of Advisory Committee: Dr. Robert S. Chapkin 
 
Correct localization of lipidated cytosolic proteins to the plasma membrane (PM) is 
mediated by interactions between lipid anchors of proteins and cell membranes.  
Previously, dietary fish oil and its major n-3 polyunsaturated fatty acid (PUFA), 
docosahexaenoic acid (DHA), have been shown to decrease Ras membrane association, 
concomitantly reducing rat colon tumor incidence and Ras signaling, compared with 
corn oil and linoleic acid (LA), a highly prevalent vegetable fat and dietary PUFA in the 
U.S. diet.  In order to explore the potential regulatory role of the cellular lipid 
environment in PM targeting of lipidated proteins, young adult mouse colon (YAMC) 
cells were treated with 50 µM DHA, LA, or oleic acid (OA) 24 h prior to and 36-48 h 
after transfection with green fluorescent protein (GFP) fusion constructs of various 
lipidated cytosolic proteins.  Relative expression of each GFP fusion protein at the PM 
and the Golgi in living cells was quantified using z-serial confocal microscopy and 
digital image processing.  DHA differentially altered the subcellular localization of Ras 
isoforms and Src-related tyrosine kinases in a reversible manner.  DHA significantly 
decreased the PM localization and increased the endomembrane association of H-Ras, 
 
 iv
N-Ras, and Lck, which are targeted to the PM via the exocytic pathway, regardless of 
their functional state.  In contrast, the subcellular distribution of K-Ras and Fyn, of 
which transport is independent of the vesicular transport pathway, was unaffected by 
DHA.  Moreover, DHA selectively inhibited lipidated cytosolic protein targeting since 
the PM delivery of transmembrane protein cargo was unaffected, indicating that DHA 
does not alter the bulk flow of secretory vesicular traffic.  Overall, the present study 
presents compelling evidence that select dietary constituents with membrane lipid-
modifying properties can differentially modulate subcellular localization of important 
lipidated signaling proteins depending on their intracellular trafficking route to the PM. 
 
 
 v
DEDICATION 
 
I would like to dedicate this dissertation to my parents, Tea Young Seo, and Kui Ja 
Yoon, and to my grandmother, Sun Hee Lee, whose unconditional love and support 
always inspire me to do my best to be a better person. 
 
 
 vi
ACKNOWLEDGEMENTS 
 
I sincerely thank Dr. Robert Chapkin for his continuous support and invaluable guidance 
throughout my graduate program.  It has been a real pleasure to work with such a nice 
mentor.  I would like to extend my thanks to everyone in the Chapkin lab, especially Dr. 
Laurie Davidson, Evelyn Callaway, Yee Voon Ng, and Kristin Guess, for being there for 
me and for their friendship. 
I would like to offer my special thanks to Dr. Rola Barhoumi, for her tremendous 
help with image acquisition and for helpful discussions.  I thank Dr. Edward Dougherty 
and his graduate student, Ashish Choudhary, for their help with the algorithm 
development, and Dr. Naisyin Wang for her help with statistical anaylsis. 
I was truly lucky to have such a wonderful advisory committee for my research 
program.  I learned a lot of science from Drs. Arthur Johnson, Joanne Lupton, and 
Robert Burghardt.  More importantly, I learned “more” than science from each and every 
one of them, for which I cannot thank them enough. 
I wish to take this opportunity to thank my parents and dearest friends in Korea 
for I am who I am today because of their endless love, support, and friendship. 
 
 vii
TABLE OF CONTENTS 
 Page 
ABSTRACT .................................................................................................................... iii 
DEDICATION ..................................................................................................................v 
ACKNOWLEDGEMENTS .............................................................................................vi 
TABLE OF CONTENTS ............................................................................................... vii 
LIST OF FIGURES..........................................................................................................ix 
LIST OF ABBREVIATIONS ..........................................................................................xi 
CHAPTER 
 I INTRODUCTION..............................................................................................1 
 II LITERATURE REVIEW...................................................................................5 
   Protein lipidation ..........................................................................................5 
   Post-translational processing and intracellular trafficking of Ras .............17 
   Membrane properties of DHA....................................................................22 
 III MATERIALS AND METHODS .....................................................................35 
  Reagents and plasmids ...............................................................................35 
  Cell culture and transfection ......................................................................36 
  Preparation of fatty acid-albumin complex................................................37 
  Confocal microscopy .................................................................................38 
  Quantification of subcellular localization of GFP-labeled proteins...........40 
  Statistical analysis ......................................................................................44 
 IV RESULTS.........................................................................................................46 
 DHA alters PM targeting and subcellular distribution of GFP-Nras-wt....46 
DHA alters intracellular trafficking of GFP-Hras but not GFP-Kras 
to the PM regardless of their mutation status.............................................51 
DHA-induced alterations in Ras trafficking are independent of Ras 
signaling .....................................................................................................62 
DHA effects on intracellular Ras trafficking to the PM are reversible......66 
DHA suppresses PM localization of Lck but not Fyn................................69 
 
 viii
CHAPTER Page 
DHA does not alter intracellular trafficking of VSVG-GFP to the PM.....74 
 V DISCUSSION ..................................................................................................80 
 VI CONCLUSIONS............................................................................................100 
REFERENCES..............................................................................................................102 
VITA .............................................................................................................................141
  
 
 
 
 ix
LIST OF FIGURES 
FIGURE Page 
1 Examples of lipidated PM signaling proteins .......................................................6 
2 Domain structure of Ras isoforms.......................................................................19 
3 Post-translational processing and intracellular trafficking of Ras isoforms .......21 
4 Summarized experimental time course ...............................................................39 
5 Confocal serial optical sections of a living YAMC cell stained with FM 4-64 ..41 
6 Analytical procedure to quantify the relative subcellular localization 
 of GFP-labeled proteins ......................................................................................42 
7 DHA alters the subcellular distribution of GFP-Nras-wt....................................48 
8 DHA decreases PM localization and increases Golgi association 
 of GFP-Nras-wt ...................................................................................................50 
9 DHA alters the subcellular distribution of GFP-Hras-wt....................................53 
10 DHA decreases PM localization and increases Golgi association of 
 GFP-Hras-wt .......................................................................................................54 
11 Subcellular distribution of GFP-Kras-wt is not altered by fatty acid treatment..55 
12 PM localization of GFP-Kras-wt is not altered by fatty acid treatment..............56 
13 DHA alters the subcellular distribution of GFP-HrasG12V ...............................58 
14 DHA decreases PM localization and increases Golgi association 
 of GFP-HrasG12V...............................................................................................59 
15 Subcellular distribution of GFP-KrasG12V is not altered 
 by fatty acid treatment.........................................................................................60 
16 PM localization of GFP-KrasG12V is not altered by fatty acid treatment .........61 
17 DHA alters the subcellular distribution of GFP-tH.............................................64 
18 DHA decreases PM localization of GFP-tH .......................................................65 
 
 x
FIGURE Page 
19 Subcellular distribution of GFP-tK is not altered by fatty acid treatment ..........67 
20 PM localization of GFP-tK is not altered by fatty acid treatment.......................68 
21 DHA-induced alterations in GFP-tH subcellular localization are reversible ......70 
22 DHA alters the subcellular distribution of Lck-GFP ..........................................72 
23 DHA decreases PM localization of Lck-GFP .....................................................73 
24 Subcellular distribution of Fyn-GFP is not altered by fatty acid treatment ........75 
25 PM localization of Fyn-GFP is not altered by fatty acid treatment ....................76 
26 Subcellular distribution of VSVG-GFP is not altered by fatty acid treatment....78 
27 PM localization of VSVG-GFP is not altered by fatty acid treatment................79 
 
 
 xi
LIST OF ABBREVIATIONS 
 
ARF, ADP-ribosylation factor 
BSA, bovine serum albumin 
DHA, docosahexaenoic acid 
DPH, 1,6-diphenylhexatriene 
eNOS, endothelial nitric oxide synthase 
EPA, eicosapentaenoic acid 
ER, endoplasmic reticulum 
FBS, fetal bovine serum 
FPP, farnesyl pyrophosphate 
FTase, farnesyl transferase 
GFP, green fluorescent protein 
GGTase, geranylgeranyl transferase 
GPI, glycosylphosphatidylinositol 
HIV-1, human immunodeficiency virus-1 
HMG-CoA, hydroxymethylglutaryl CoA 
IFN-γ, interferon-γ 
ITS, insulin/transferrin/selenium 
LA, linoleic acid 
MARCKS, myristoylated alanine-rich C kinase substrate 
N.A., numerical aperture 
 
 xii
NBD, 7-nitrobenz-2-oxa-1,3-diazol-4-yl 
NMR, nuclear magnetic resonance 
NMT, N-myristoyl transferase 
NRTK, nonreceptor tyrosine kinase 
OA, oleic acid 
PC, phosphatidylcholine 
PE, phosphatidylethanolamine 
PLD, phospholipase D 
PM, plasma membrane 
PS, phosphatidylserine 
PUFA, polyunsaturated fatty acid 
REP, Rab escort protein 
ROI, region of interest 
TGN, trans-Golgi network 
VSVG, vesicular stomatitis virus glycoprotein 
YAMC, young adult mouse colon 
 
 1
CHAPTER I 
INTRODUCTION 
 
Correct subcellular localization of proteins within numerous membrane-bounded 
intracellular compartments is essential for the fidelity and efficiency of their function.  In 
particular, in the case of specific signaling proteins that transduce the external signals 
acquired by cell surface receptors to multiple downstream effectors, their correct 
targeting to the cytoplasmic surface of the plasma membrane (PM) is critical for the 
ability of cells to communicate with and respond to the external environment 
(Kholodenko et al., 2000).   
Membrane association of otherwise cytosolic soluble proteins is often achieved 
by regulated processes such as covalent modification of proteins with specific lipid 
anchors (Casey, 1995).  The most common types of cytosolic protein lipidation in 
eukaryotic cells are fatty acylation with myristate (14:0) or palmitate (16:0) and 
prenylation with 15-carbon farnesyl or 20-carbon geranylgeranyl moieties (Resh, 1999; 
Roskoski, 2003).  Many cytosolic proteins are specifically targeted to the PM by means 
of a combination of two different membrane anchors.  This two-signal model often 
features myristate or polyisoprenoid combined with palmitate or a polybasic domain 
(Casey, 1995; Hancock et al., 1990; Resh, 1994; Resh, 1996), which appear to be 
functionally interchangeable (Cadwallader et al., 1994; Kwong and Lublin, 1995; Zhou 
et al., 1994).  For example, polyisoprenyl groups must work in concert with palmitate at  
_______________ 
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the C-terminus of H-Ras, N-Ras, RhoB, and TC10 for correct PM targeting, while K-
Ras4B and members of Rho family including Rac1 use a polybasic stretch of amino 
acids in conjunction with polyisoprenoids (Cadwallader et al., 1994; Hancock et al., 
1990; Michaelson et al., 2001; Williams, 2003).  Seven of the nine Src family members 
including Lck and Fyn and at least five α subunits of heterotrimeric G proteins are 
modified by N-terminal dual acylation with myristate and palmitate to achieve PM 
localization (Koegl et al., 1994; Linder et al., 1993; Parenti et al., 1993; Resh, 1994).  A 
combination of myristate and clusters of basic amino acids can be found in N-terminal 
targeting regions of Src, myristoylated alanine-rich C kinase substrate (MARCKS), and 
human immunodeficiency virus-1 (HIV-1) Gag protein (Kim et al., 1994; McLaughlin 
and Aderem, 1995; Sigal et al., 1994; Zhou et al., 1994). 
Recent work has revealed that lipidated cytosolic proteins are transported to the 
PM via different intracellular trafficking routes.  Elegant studies with biochemical, 
fluorescence and electron microscopic approaches demonstrated that after common 
processing on the cytosolic surface of the ER, H-Ras and N-Ras traffic to the PM via the 
classical exocytic pathway while K-Ras4B takes an uncharacterized faster route that is 
independent of the Golgi-mediated vesicular transport (Apolloni et al., 2000; Choy et al., 
1999).  Similar to H- and N-Ras, newly synthesized Lck, neuromodulin (also known as 
GAP-43), and synaptosomal-associated protein of 25 kDa (also know as SNAP-25) have 
been shown to initially associate with intracellular membranes and subsequently travel 
through the secretory pathway to the PM (Bijlmakers and Marsh, 1999; Gonzalo and 
Linder, 1998; Liu et al., 1994).  In contrast, Fyn and Moloney murine leukemia virus 
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Gag protein are targeted rapidly and directly to the PM after biosynthesis on soluble 
ribosomes (Suomalainen et al., 1996; van't Hof and Resh, 1997), indicating that at least 
two transport pathways exist for PM targeting of lipidated cytosolic proteins, differing in 
the dependence on the secretory vesicular transport. 
While many PM-associated upstream signaling proteins such as Ras and Src 
family kinases play essential roles in a variety of cellular functions, their chronic 
overactivation has contributed to deleterious cellular malfunction including oncogenesis 
and inflammatory diseases (Bos, 1989; Campbell and Der, 2004; Orchard, 2002; Singer 
and Koretzky, 2002).  Consequently, substantial efforts have been devoted to develop 
therapeutic agents to inhibit Ras and tyrosine kinase function with some promising 
progress (Garcia-Echeverria, 2001; Kamens et al., 2001; Kloog and Cox, 2000; Levitzki, 
1994; Lodge et al., 1998; McWherter et al., 1997; Wittinghofer and Waldmann, 2000; 
Wong and Leong, 2004).  Co-translational and post-translational modifications 
responsible for protein PM targeting have been extensively studied and subsequently 
exploited in the development of farnesyl transferase- and N-myristoyl transferase-
directed drugs for inhibition of protein membrane association (Brunner et al., 2003; 
Bryant and Ratner, 1990; Bryant et al., 1991; Johnson et al., 1994; Prendergast, 2000).  
However, the potential regulatory role of the cellular lipid environment in intracellular 
protein trafficking has not been well appreciated to date.  Previously, dietary fish oil and 
its major n-3 polyunsaturated fatty acid (PUFA), docosahexaenoic acid (DHA; 22:6, n-
3), have been shown to decrease Ras membrane association compared with corn oil and 
linoleic acid (LA; 18:2, n-6), which coincided with reduced colon tumor incidence and 
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Ras-dependent signaling in the carcinogen-injected rat colon and malignant transformed 
mouse colon cell line, respectively (Collett et al., 2001; Davidson et al., 1999; Singh et 
al., 1997).  However, the exact subcellular distribution of Ras in fish oil- or DHA-treated 
colon cells as well as the underlying mechanism for the reduced Ras membrane 
association has not been elucidated.  At any given time, a substantially large fraction of 
Ras is associated with the endomembrane structures such as the endoplasmic reticulum 
(ER) and the Golgi, in addition to the PM (Apolloni et al., 2000; Choy et al., 1999).  
Therefore, a reduced membrane association of Ras does not necessarily mean a 
reduction in Ras PM localization.  Using green fluorescent protein (GFP) fusion 
chimeras and quantitative fluorescence imaging of living cells, the present study 
demonstrates that DHA differentially alters PM targeting and subcellular localization of 
Ras isoforms and Src-related tyrosine kinases in colonic epithelial cells in a reversible 
manner.  DHA significantly decreased the PM localization and increased the 
endomembrane association of H-Ras, N-Ras, and Lck, which are targeted to the PM via 
the exocytic pathway, regardless of their functional state.  In contrast, subcellular 
distribution of K-Ras-4B and Fyn, of which transport is independent of the vesicular 
transport pathway, was unaffected by DHA.  Moreover, DHA seems to selectively 
inhibit lipidated cytosolic protein targeting since the PM delivery of transmembrane 
protein cargo was unaffected.  Overall, the present study presents compelling evidence 
that select dietary constituents with membrane lipid-modifying properties can 
differentially modulate subcellular localization of important lipidated signaling proteins 
depending on their intracellular trafficking route to the PM. 
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CHAPTER II 
LITERATURE REVIEW 
 
Protein lipidation 
The ability of cells to communicate with and respond to the external environment entails 
that the external signals must somehow penetrate through the plasma membrane (PM) 
lipid bilayers and reach the intracellular networks of signaling machinery.  In most cases, 
the external signaling entity does not directly enter the cell but rather transmits its 
information to specific cell surface receptors.  These cell surface receptors subsequently 
communicate with specific signaling proteins present on the cytoplasmic surface of the 
PM, which, in turn, relay the information to multiple intracellular downstream effectors.  
Membrane association of such specific signaling proteins often depends on their 
covalent modification by specific lipid moieties.  This regulated process of protein 
lipidation can be subdivided into four major categories based on the identity of the lipid 
attached to the protein: fatty acylation, prenylation, glypiation, and cholesteroylation 
(Casey, 1995; Mann and Beachy, 2000).  Examples of proteins with different lipid 
modifications are illustrated in Fig. 1. 
Fatty acylation 
 The two most common types of protein fatty acylation are modification with 
palmitate (16:0), a 16-carbon saturated fatty acid, and myristate (14:0), a 14-carbon 
saturated fatty acid.  Whereas the enzymology of myristoylation reaction is extensively 
6 
Figure 1.  Examples of lipidated PM signaling proteins.  Palmitoylated proteins are exemplified by G protein-coupled 
receptor (GPCR), heterotrimeric Gα subunits, Hedgehog (Hh) morphogen, Yes nonreceptor tyrosine kinase (NRTK), and H- 
and N-Ras small GTPases.  Myristoylation can be found in Yes NRTK, and Gα subunits.  Prenylation with farnesyl and 
geranylgeranyl moieties is exemplified by Ras GTPases and Gγ subunits, respectively.  Glypiation and cholesteroylation is 
found in placental alkaline phosphatase (PAP) and Hh, respectively, both of which are on the cell exterior.  Prenyl, GPI, 
palmitoyl, and myristoyl groups are shown in blue, orange, pink, and green, respectively.  p, phosphate.  pEtN, 
phosphoethanolamine.  Adapted from Berthiaume (Berthiaume, 2002). 
palmitoyl
myristoylglycosylphosphatidylinositol
pEtN
p
geranylgeranyl or farnesyl
Hh
αβ γ Yes H/N-Ras
G protein
GPCR
NRTK
p
pEtN
PAP
PM
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characterized, the molecular basis of palmitoylation reaction seems more complex and 
dynamic and is poorly understood to date. 
 In nearly all palmitoylated proteins, palmitate is attached to the sulfhydryl group 
of cysteine residues via a labile thioester bond in a post-translational fashion, with the 
exception of human Sonic Hedgehog proteins, in which palmitate is attached to the 
amino group of N-terminal cysteine via an amide bond (Pepinsky et al., 1998).  
Examples of palmitoylated proteins include H-Ras, N-Ras, α subunits of heterotrimeric 
G proteins, Src family of nonreceptor tyrosine kinases (NRTKs) and G protein-coupled 
receptors (Alland et al., 1994; Bouvier et al., 1995; Hancock et al., 1989; Linder et al., 
1993).  The location of palmitoylated cysteine residues varies such that they can be 
found at the N- or C-terminal region or near transmembrane domains (Resh, 1996).  
Although palmitate is the predominant fatty acid linked to the cysteine residue of 
proteins, other fatty acyl chains can be incorporated in place of palmitate (Bizzozero et 
al., 1986; Casey et al., 1994; Fujimoto et al., 1993; Hallak et al., 1994; Muszbek and 
Laposata, 1993; O'Brien et al., 1987).  Thus, the term ‘S-acylation’ may provide a more 
accurate description of this type of modification (Casey, 1995).  The lability of thioester 
linkage renders the palmitoylation process reversible and dynamic unlike other 
permanent lipid modifications, presenting a unique potential to be regulated.  Indeed, 
regulation of protein palmitoylation has previously been reported, as exemplified by the 
agonist-stimulated turnover of palmitate on β2-adrenergic receptor, α subunit of Gs 
protein, and endothelial nitric oxide synthase (eNOS) (Degtyarev et al., 1993; Mouillac 
et al., 1992; Mumby et al., 1994; Robinson et al., 1995; Wedegaertner and Bourne, 
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1994).  Moreover, the activation-induced depalmitoylation of Gsα and eNOS was 
accompanied by cytosolic translocation of these proteins, indicating that the dynamic 
acylation state of proteins may regulate protein subcellular localization (Robinson et al., 
1995; Wedegaertner and Bourne, 1994).  Unfortunately, the molecular mechanism of 
protein palmitoylation has been poorly understood to date and enzymes responsible for 
protein palmitoylation have defied purification until recently.  Partial purification of 
protein palmitoyl transferase activities towards different proteins and peptides has been 
reported from several membrane compartments including the ER, the Golgi, the ER-
Golgi intermediate compartment, and the PM (Dunphy et al., 1996; Gutierrez and 
Magee, 1991; McLaughlin and Denny, 1999; Schroeder et al., 1996; Zhao et al., 2002).  
Two yeast genes (erf2 and erf4) responsible for Ras palmitoylation have recently been 
cloned and await further characterization (Bartels et al., 1999; Lobo et al., 2002).  Two 
thioesterases have been identified to depalmitoylate Ras and Gα proteins in vitro (Camp 
et al., 1994; Duncan and Gilman, 1998) and it is likely that additional protein palmitoyl 
thioesterases exist.  In addition, non-enzymatic palmitoylation of proteins has been 
documented (Bano et al., 1998; Duncan and Gilman, 1996), although the physiological 
relevance of this spontaneous autoacylation mechanism has not yet been resolved.  
Clearly, further progress in the identification and characterization of protein palmitoyl 
transferases and thioesterases is needed to better understand the role of palmitoylation in 
regulating the localization and function of signaling proteins. 
 Myristoylated proteins contain myristate typically attached to the N-terminal 
glycine residue via an amide bond in a co-translational manner, as exemplified by Src 
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family NRTKs, Gα subunits, recoverin, MARCKS, and mammalian retroviral Gag 
proteins (Resh, 1999).  All known myristoylated proteins initiate with the sequence of 
Met-Gly.  The initiating methionine is removed by methionine amino peptidase during 
translation and the now N-terminal glycine is myristoylated by N-myristoyl transferase 
(NMT), a 50-60 kDa monomeric enzyme (Gordon et al., 1991).  NMT resides 
predominantly in the cytoplasm although membrane-associated NMT activity has also 
been documented (McIlhinney, 1995; McIlhinney and McGlone, 1996).  The catalytic 
mechanism and substrate specificities of NMT are extensively characterized and 
reviewed (Devadas et al., 1992; Johnson et al., 1994; Kishore et al., 1993; Rudnick et al., 
1990).  NMT exhibits a remarkable specificity to myristate and longer or shorter fatty 
acyl CoAs are poor substrates for this reaction.  However, select retinal proteins, HIV-1 
Gag protein, and Fyn have been reported to be heterogeneously acylated via an amide 
bond with lauric acid (12:0), 5-cis-tetradecenoic acid (14:1, n-9), and 5-cis,8-cis-
tetradecadienoic acid (14:2, n-6) in addition to myristate (14:0) in vivo (Dizhoor et al., 
1992; Kokame et al., 1992; Liang et al., 2001; Lindwasser and Resh, 2002).  A subset of 
myristoylated proteins such as ADP-ribosylation factor (ARF) and recoverin exists in 
two conformations differing in the orientation of myristate relative to the protein 
(Goldberg, 1998; Tanaka et al., 1995).  In these proteins, myristate is either sequestered 
within a hydrophobic cleft of the protein or exposed to the protein surface, thereby being 
able to participate in membrane binding.  The transition between these two 
conformations is regulated by a mechanism known as the ‘myristoyl switch’ 
(McLaughlin and Aderem, 1995).  The triggers for the switch include ligand binding, 
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electrostatics, and proteolysis.  Myristoyl switch proteins typically exhibit reversible 
membrane association as illustrated by Ca2+-sensitive membrane binding of recoverin 
(myristoyl-ligand switch) (Ames et al., 1994; Tanaka et al., 1995), GTP-binding-
stimulated translocation of ARF from the cytosol to membranes (myristoyl-ligand 
switch) (Amor et al., 1994; Goldberg, 1998; Haun et al., 1993), phosphorylation-
mediated translocation of MARCKS from membranes to the cytosol (myristoyl-
electrostatic switch) (Kim et al., 1994; McLaughlin and Aderem, 1995; Thelen et al., 
1991), and cleavage-triggered release of HIV-1 Gag from membranes (myristoyl-
proteolytic switch) (Hermida-Matsumoto and Resh, 1999).  In addition to the role in 
membrane binding, myristoylation plays a structural role to stabilize three-dimensional 
conformation as revealed by crystal structures of the poliovirus protein shell and the 
catalytic subunit of cAMP-dependent kinase (Chow et al., 1987; Zheng et al., 1993). 
Prenylation 
 Prenylation refers to the covalent attachment of either 15-carbon farnesyl or 20-
carbon geranylgeranyl isoprenoids to one or more cysteines at or near the C-terminus of 
proteins.  The branched unsaturated prenyl group is attached via a stable thioether bond 
in a post-translational process.  The lipid substrates for prenylation are farnesyl 
pyrophosphate (FPP) and geranylgeranyl pyrophosphate, which are built from isoprene 
units derived from the mevalonate pathway (Goldstein and Brown, 1990).  The enzymes 
responsible for prenylation have been identified and characterized at a molecular level 
(Casey and Seabra, 1996; Roskoski, 2003).  Three distinct protein prenyl transferases 
can be subdivided into two functional classes.  Protein farnesyl transferase (FTase) and 
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protein geranylgeranyl transferase I (GGTase I) are classified as the CAAX prenyl 
transferase and Rab geranylgeranyl transferase or protein geranylgeranyl transferase II 
(GGTase II) constitutes the second class of prenyl transferase.  All three prenyl 
transferases are zinc metalloenzymes, and FTase and GGTase II but not GGTase I 
require Mg2+ for activity (Reiss et al., 1992; Zhang and Casey, 1996a; Zhang et al., 
2000). 
 FTase and GGTase I are designated as CAAX prenyl transferase since they 
catalyze the prenylation of the fourth cysteine from the C-terminus of proteins 
containing a C-terminal tetrapeptide sequence called a CAAX box, where C stands for 
cysteine, A stands for an aliphatic residue and X typically refers to methionine, serine, 
alanine, or glutamine for FTase or to leucine for GGTase I (Clarke, 1992; Zhang and 
Casey, 1996b).  Based on biochemical and structural analyses, ‘molecular ruler’ and 
‘second site exclusion’ hypotheses have been proposed to explain different isoprenoid 
substrate specificities of prenyl transferases (Long et al., 1998; Turek-Etienne et al., 
2003).  Both FTase and GGTase I can recognize short peptides containing appropriate 
CAAX motifs as substrates in addition to their physiological substrates.  The total 
number of likely substrates for FTase is about 50 and is about a hundred for GGTase I 
(Cox and Der, 1997).  Examples of FTase substrates include Ras, lamin B, several 
proteins involved in visual signal transduction, and fungal mating factors.  Known 
GGTase I targets include most Gγ subunits, and members of Ras-related Rac/Rho family 
GTPases.  In general, following prenylation, most CAAX proteins are directed to a 
membrane compartment for further processing driven by the CAAX motif.  The terminal 
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three residues (AAX) are sequentially removed by a CAAX endopeptidase and the 
carboxyl group of the now C-terminal prenylcysteine is methylesterified (Clarke, 1992; 
Zhang and Casey, 1996b).  CAAX prenyl transferases generally exhibit remarkable 
selectivity for their protein substrates.  However, a few exceptions to the above-
mentioned substrate specificity for FTase and GGTase I have been observed as in the 
case of K-Ras4B and RhoB (Armstrong et al., 1995; James et al., 1995).  Both FTase 
and GGTase I are heterodimers that share a common 49 kDa α subunit but contain 
distinct β subunits, exhibiting combined molecular masses of 94 and 91 kDa, 
respectively (Moomaw and Casey, 1992; Reiss et al., 1990; Seabra et al., 1991; 
Yokoyama and Gelb, 1993). 
 GGTase II attaches geranylgeranyl groups to two C-terminal cysteines in Rab 
family (Ypt/Sec4 in lower eukaryotes) proteins that terminate in Cys-Cys or Cys-X-Cys 
sequences (Glomset and Farnsworth, 1994; Seabra et al., 1992).  Rab family small 
GTPases function as molecular switches regulating membrane traffic (Seabra et al., 
2002) and all Rab proteins tested to date are substrates for GGTase II.  Rab proteins 
ending with Cys-X-Cys residues are methylesterified but those with Cys-Cys are not.  
GGTase II is a heterodimer composed of a 60 kDa α subunit and a 38 kDa β subunit that 
are homologous to α and β subunits of CAAX prenyl transferases (Armstrong et al., 
1993; Brown and Goldstein, 1993).  Unlike FTase and GGTase I, GGTase II does not 
recognize peptide substrates because the actual substrate recognized by GGTase II is a 
complex of Rab and a Rab escort protein (REP).  REP binds newly synthesized Rab 
proteins and presents them to GGTase II for prenylation (Andres et al., 1993; Cremers et 
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al., 1994).  The findings that defects in REP are implicated in a retinal degeneration 
disease, choroideremia, underscores the important role of prenylation in Rab function 
(Seabra et al., 1993). 
 Characterization of the kinetic mechanism and reaction pathway of FTase has 
rapidly progressed although the understanding of GGTase I and II is not as complete as 
that of FTase.  Metals are required for direct catalytic roles rather than for substrate 
binding as revealed by metal substitution and X-ray crystallographic studies (Hightower 
et al., 1998; Huang et al., 1997; Saderholm et al., 2000).  The transition state of the 
associative mechanism of farnesylation reaction involves a Zn2+-activated thiolate 
nucleophile (RS:−) of cysteine, which attacks the carbocation at C1 of FPP, and a Mg2+-
coordinated pyrophosphate leaving group (Dolence and Poulter, 1995; Huang et al., 
2000).  Kinetic and structural data indicate that the reaction catalyzed by FTase is 
sequential, with the release of a farnesylated protein product being the rate-limiting step 
(Furfine et al., 1995; Long et al., 2002; Tschantz et al., 1997).  In this proposed reaction 
pathway, FPP initially binds to the free enzyme, followed by peptide binding and 
farnesylation of the peptide.  Subsequently, a pyrophosphate is released, yielding the 
FTase/farnesylpeptide complex.  Dissociation of the farnesylpeptide product from the 
enzyme requires an addition of fresh substrate(s). 
Glypiation 
 Glypiation refers to the post-translational modification of proteins by a complex 
glycosylphosphatidylinositol (GPI) structure (Englund, 1993).  GPI-anchored proteins 
are a functionally diverse class of proteins that are attached to the exoplasmic leaflet of 
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the PM by means of a GPI moiety.  This ubiquitous modification was discovered in the 
late 1970s when phosphatidylinositol-specific phospholipase C was shown to 
specifically release alkaline phosphatase, acetylcholinesterase, and 5’-nucleotidase from 
cell membranes (Low and Finean, 1978; Shukla et al., 1980).  To date, approximately 
100 distinct GPI-anchored proteins have been identified (Low, 1999).  The core structure 
of the GPI anchor consists of a single phospholipid spanning the exoplasmic leaflet of 
the PM and a complex head group composed of an inositol, a glucosamine, a linear chain 
of three mannose sugars, and a phosphoethanolamine.  The protein is attached to the GPI 
moiety via an amide bond between the C-terminal residue of the protein and the amino 
group of the phosphoethanolamine.  Variations in the GPI structure occur in both the 
lipid part and the tetrasaccharide backbone, although the core structure is conserved 
across all species studied to date (McConville and Ferguson, 1993). 
 GPI-anchored proteins are initially directed into the ER lumen by means of an N-
terminal signal sequence during translation, where they are post-translationally modified 
by a pre-assembled GPI moiety (Ferguson, 1999).  After glypiation, essentially all of 
those modified proteins are destined for the cell surface through the classical exocytic 
pathway (Lippincott-Schwartz et al., 2000).  GPI biosynthesis initiates on the cytosolic 
face of the ER and the fully assembled GPI structure is transferred to the protein in the 
ER lumen (Vidugiriene and Menon, 1994).  Therefore, the cytoplasmically located GPI 
precursors must be flipped across the bilayers into the lumen prior to the attachment to 
the protein.  However, the topology of each enzymatic step of the sequential GPI 
biosynthesis has not been fully resolved (McConville and Menon, 2000).  Attachment of 
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a GPI anchor involves the cleavage of the C-terminal transmembrane segment of the 
protein for the exposure of the GPI addition site, followed by a transamidation reaction 
linking the complete GPI moiety to the cleaved ectodomain of the protein (Udenfriend 
and Kodukula, 1995).  The protein remains membrane-bound with all of its amino acids 
exposed initially on the luminal side of the ER and eventually on the cell exterior. 
 In addition to its role as a membrane anchor, the GPI moiety functions as an 
apical-targeting signal, directing proteins to the apical domain of polarized epithelial 
cells (Brown et al., 1989; Lisanti et al., 1989).  Moreover, the GPI anchor has been 
shown to act as a sorting determinant at an early step in the exocytic pathway, i.e., exit 
from the ER (Muniz et al., 2001; Muniz et al., 2000), and in the endocytic pathway 
(Sabharanjak et al., 2002). 
Cholesteroylation 
 Cholesteroylation involves the post-translational modification of proteins with 
cholesterol, as exemplified by the Hedgehog family of tissue patterning factors (Mann 
and Beachy, 2000).  Similar to glypiated proteins, Hedgehog proteins are modified 
within the secretory pathway, and their final destination is the outer layer of the PM.  
Upon entry into the secretory pathway followed by cleavage of an N-terminal signal 
sequence, Hedgehog protein undergoes an autocatalytic processing mediated by its C-
terminal processing domain (Lee et al., 1994; Porter et al., 1995).  The autoprocessing 
results in an internal cleavage to release an N-terminal signaling domain.  In addition, 
the C-terminal processing domain functions as a cholesterol transferase via an 
intramolecular mechanism, facilitating direct nucleophilic attack of cholesterol on the 
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thioester intermediate to form an ester-linked cholesterol adduct at the C-terminus of the 
signaling domain (Porter et al., 1996b).  Cholesteroylation is crucial for the spatially 
restricted tissue localization of the Hedgehog signal, preventing an inappropriate 
influence beyond its expression site (Porter et al., 1996a). 
Membrane binding of lipidated cytosolic proteins 
 The most common types of lipid modification of cytosolic proteins are fatty 
acylation and prenylation (Resh, 1999; Roskoski, 2003).  Most lipidated cytosolic 
proteins are membrane-bound in eukaryotic cells and studies with fatty acid probes have 
shown that fatty acyl groups attached to proteins are embedded within the lipid bilayers 
(Moench et al., 1994; Vergeres et al., 1995).  In general, site-directed mutagenesis of the 
modified amino acids, i.e., cysteine or glycine, abolishes incorporation of the lipid 
moiety and markedly reduces membrane association of cytosolic proteins (Hancock et 
al., 1989; Resh, 1993).  Therefore, lipid modification seems to be necessary for the 
membrane association of certain cytosolic proteins.  However, some lipid modifications 
have been suggested to be insufficient to promote stable membrane association.  The 
unitary Gibbs free energy for binding of a myristoylated peptide to phospholipid bilayers 
has been estimated as 8 kcal/mol, equivalent to an apparent dissociation constant (Kd) of 
10−4 M (Peitzsch and McLaughlin, 1993) and a similar binding affinity has been reported 
for farnesylated peptides (Silvius and l'Heureux, 1994).  These lipopeptide studies 
predict that the presence of myristate or farnesyl moiety alone may not be sufficient to 
stably anchor a protein to cellular membranes.  Consistent with this notion, membrane 
association of myristoylated or farnesylated proteins often involves additional factors 
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such as the presence of palmitate or a stretch of basic amino acids (Casey, 1995; 
Hancock et al., 1990; Resh, 1994; Resh, 1996). 
 
Post-translational processing and intracellular trafficking of Ras 
One of the best-studied examples of the lipidation-mediated protein targeting 
mechanisms is the PM targeting of the small GTPase Ras.  Ras is a crucial component of 
numerous signal transduction pathways that link diverse extracellular stimuli to the 
control of cell growth, differentiation, and survival (Shields et al., 2000).  Ras genes (H-
ras, N-ras, and K-ras) are the most frequently mutated protooncogenes both in animal 
and human cancers (Bos, 1989), producing constitutively GTP-bound active forms when 
mutated.  The aberrant Ras signaling caused by either mutational activation of Ras or 
chronic up-regulation of upstream receptors plays a key role in human malignancies 
including colon cancer (Campbell and Der, 2004; Houlston, 2001; Janes et al., 1994).  
The major signaling platform of Ras proteins is the PM and the localization at the inner 
leaflet of the PM is required for both normal and oncogenic activities of Ras (Der and 
Cox, 1991; Kato et al., 1992).  However, recent studies revealed that Ras can engage 
different signaling pathways with distinct kinetics in endomembranes including the 
Golgi, the ER, and endosomes as well as at the PM (Arozarena et al., 2004; Bivona et 
al., 2003; Caloca et al., 2003; Chiu et al., 2002; Hancock, 2003; Jiang and Sorkin, 2002; 
Perez de Castro et al., 2004). 
 ras genes encode four Ras isoforms, H-Ras, N-Ras, K-Ras4A, and K-Ras4B, 
with the latter two being alternative splicing variants of K-ras gene.  Mammalian cells 
 
  
18
ubiquitously express three main isoforms, H-Ras, N-Ras, and K-Ras4B, whereas K-
Ras4A is expressed in only a limited number of tissues including small and large 
intestines (Plowman et al., 2003).  Despite the 85% overall sequence homology, Ras 
isoforms exhibit distinct biological properties as evidenced by substantial differences in 
the mutation frequency in different types of cancer (Bos, 1989), the role in normal 
mouse embryo development (Johnson et al., 1997; Koera et al., 1997; Plowman et al., 
2003; Umanoff et al., 1995), the activation profile of their common downstream 
effectors (Voice et al., 1999; Walsh and Bar-Sagi, 2001; Yan et al., 1998), and cellular 
function (de Castro et al., 2003; Santillo et al., 2001; Wolfman and Wolfman, 2000).  
The mechanism responsible for the PM targeting of three main Ras isoforms is well 
understood.  The PM targeting domain of each Ras isoform consists of the C-terminal 
CAAX motif, common to all isoforms, and distinct second signal sequences (Fig. 2). 
This PM targeting domain contains all the necessary and sufficient information for Ras 
PM targeting, directing not only the sequential post-translational processing of each Ras 
isoform but also their distinct intracellular trafficking route to the PM (Apolloni et al., 
2000; Choy et al., 1999; Prior et al., 2001).  Initially synthesized as cytosolic soluble 
proteins, Ras undergoes a series of post-translational modifications to form mature 
lipidated proteins that associate with the PM (Silvius, 2002).  This process is initiated by 
a C-terminal CAAX motif, which is farnesylated in the cytoplasm and then AAX 
proteolyzed and methylesterified on the cytosolic surface of the ER.  Upon completion 
of the common CAAX processing, H- and N-Ras are further modified with one (N-Ras) 
or two (H-Ras) palmitates for their second targeting signal and traffic to the PM via the 
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Figure 2.  Domain structure of Ras isoforms.  The N-terminal catalytic domains (amino acids 1-165) harboring all the 
binding sites for effectors, exchange factors, and a nucleotide are highly conserved (90-100%) in all Ras isoforms.  The C-
terminal hypervariable region is significantly divergent, exhibiting less than 10-15% sequence identity between any two 
isoforms.  The hypervariable region can be divided into the PM targeting domain and the linker domain.  The PM targeting 
domain consists of the C-terminal CAAX motif, common to all Ras isoforms, and distinct second signal sequences.  The 
second signal (shown in pink) comprises two palmitoylation sites (C181 and C184) in H-Ras, a single palmitoylation site 
(C181) in N-Ras, or a polybasic domain of six contiguous lysine residues (K175-K180) in K-Ras4B.  Adapted from Hancock 
(Hancock, 2003). 
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Golgi-mediated classical exocytic pathway (Apolloni et al., 2000; Choy et al., 1999).  
Therefore, H- and N-Ras are cytoplasmic cargo proteins of the exocytic pathway and 
their delivery to the PM relies on the membrane traffic.  In contrast, K-Ras4B utilizes a 
polybasic domain of six contiguous lysine residues for its second signal, and takes an 
uncharacterized Golgi-independent route to the PM.  Unlike H- and N-Ras, which are 
distributed throughout the secretory pathway, K-Ras4B is not detected in the Golgi by 
immunofluorescence or electron microscopy even when overexpressed and its delivery 
to the PM is insensitive to the inhibition of the constitutive secretory pathway.  Fig. 3 
summarizes the post-translational processing and intracellular trafficking route of each 
Ras isoform. 
In addition to dictating the transport pathway to the PM, distinct membrane 
anchors of Ras isoforms influence the compartmentalization into specialized PM 
microdomains.  In general, palmitoylated peripheral membrane proteins and peptides 
associate preferentially with the semi-transient, cholesterol-rich microdomains of lipid 
rafts and caveolae because the saturated palmitate readily packs into the liquid-ordered 
raft structure, whereas unsaturated, branched prenyl groups do not (Melkonian et al., 
1999; Wang et al., 2001).  While K-Ras4B predominantly resides in the disordered bulk 
PM regardless of its activation state, palmitoylated H-Ras is in a dynamic equilibrium 
between lipid rafts/caveolae and the bulk PM in a GTP loading-regulated manner 
(Hancock, 2003; Niv et al., 2002; Prior et al., 2001; Prior et al., 2003).  Palmitoylated N-
Ras seems to be targeted to the lipid rafts, similar to H-Ras (Matallanas et al., 2003).  In 
addition, H-Ras but not K-Ras signaling seems to require access to lipid rafts/caveolae, 
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Figure 3.  Post-translational processing and intracellular trafficking of Ras isoforms.  Post-translational processing of Ras 
is sequential.  After biosynthesis of nascent Ras proteins in free ribosomes, CAAX processing is initiated in the cytoplasm by 
FTase, which transfers a farnesyl group from FPP to the cysteine residue of the CAAX motif.  Farnesylated Ras is directed to 
the cytoplasmic surface of the ER, where the AAX tripeptide is removed and the now C-terminal farnesylcysteine is 
methylesterified.  Upon completion of the common CAAX processing in the ER, K-Ras4B exits the ER and takes an 
uncharacterized route to the PM, bypassing the Golgi.  In contrast, H- and N-Ras are further modified with palmitoylation 
early in the exocytic pathway, and traffic to the PM via the Golgi-mediated classical secretory pathway as cytoplasmic cargo 
proteins. 
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since perturbations of lipid rafts/caveolae by cholesterol depletion or expression of 
dominant negative caveolin blocks H-Ras but not K-Ras signaling (Carozzi et al., 2002; 
Roy et al., 1999).  Therefore, it has been proposed that the functional differences among 
Ras isoforms may be explained at least in part by the differential PM microlocalization 
mediated by distinct membrane anchors. 
 
Membrane properties of DHA 
DHA (22:6∆4,7,10,13,16,19, n-3) is the most unsaturated membrane fatty acid commonly 
found in biological systems and can be obtained by dietary consumption of cold-water 
fatty fish.  Very long chain n-3 PUFAs present in dietary fish oil, such as DHA and 
eicosapentaenoic acid (EPA; 20:5, n-3), affect diverse physiological processes including 
cognitive functions, visual acuity, eicosanoid signaling, and whole body glucose and 
lipid metabolism (Jump, 2002), thereby providing significant protection against a variety 
of unrelated human afflictions (Hu et al., 2003; Kris-Etherton et al., 2002; Rose and 
Connolly, 1999; Stulnig, 2003; Terry et al., 2003).  DHA is rapidly incorporated into 
cells, primarily into membrane phospholipids at sn-2 position (Anderson and Sperling, 
1971), and in general, the cellular DHA level is readily influenced by diet (Katan et al., 
1997; Vidgren et al., 1997).  The presence of DHA in membrane phospholipids imparts 
unique physicochemical properties to cellular membranes and DHA-induced alterations 
in membrane structure and function have been proposed to underlie the pleiotropic 
positive effects of DHA. 
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The structure of DHA in phospholipid membranes 
 Within the phospholipid bilayer structure, the order of hydrocarbon chains is 
liquid-like, characterized by rapid isomerization, rotational diffusive motions, and 
relatively unrestricted lateral diffusion.  Unsaturation has a substantial impact on the 
order and motional properties of lipids in bilayers, by lowering chain order, increasing 
chain dynamics, and changing the molecular shapes of acyl chains (Eldho et al., 2003; 
Mitchell and Litman, 1998a; Paddy et al., 1985; Salem et al., 1980; Straume and Litman, 
1987; Stubbs et al., 1981).  Chain conformations of PUFAs are greatly influenced by the 
presence of the repeating 1,4-pentadiene structural motifs (−CH=CH−CH2−CH=CH−), 
in which two double bonds are separated by a methylene group.  An earlier view on the 
PUFA structure favored a rigid arrangement of double bonds in U-shaped (Rich, 1993) 
or extended conformations such as angle iron or helical (Applegate and Glomset, 1986; 
Applegate and Glomset, 1991a; Applegate and Glomset, 1991b).  Indeed, with six 
double bonds that are locked in cis-configuration, DHA has fewer degrees of freedom 
than the corresponding saturated hydrocarbon chain, leading to the general perception 
that polyunsaturated hydrocarbon chains are rigid and bulky.  Until recently, the lower 
order parameters and faster dynamics of unsaturated chains and of labels in 
polyunsaturated membranes were often attributed to the packing perturbations from the 
introduction of bulky polyunsaturated chains.  However, recent nuclear magnetic 
resonance (NMR) structural studies and molecular dynamics simulation revealed various 
degrees of conformational flexibility of the DHA chain (Eldho et al., 2003; Everts and 
Davis, 2000; Feller et al., 2002; Gawrisch et al., 2003; Huber et al., 2002; Koenig et al., 
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1997; Rabinovich and Ripatti, 1991; Saiz and Klein, 2001).  DHA is now portrayed as a 
highly flexible molecule with rapid transitions between large numbers of conformers on 
the time scale from picoseconds to hundreds of nanoseconds (Gawrisch et al., 2003).  
Measurements of 13C spin-lattice relaxation times of the DHA chain in a lipid bilayer 
have shown that both the amplitude and frequency of motion increase towards the 
terminal methyl group (motional correlation times in the picosecond range) of DHA, 
indicating exceptional flexibility of the tail section of DHA (Eldho et al., 2003; Feller et 
al., 2002).  The low energy barriers to rotation about C−C single bonds that link the 
double bonds with the interrupting methylene carbon are responsible for this unusual 
flexibility.  Quantum mechanical calculation and molecular dynamics simulation 
estimated the energy barrier to torsional rotation about the C−C bonds of the methylene 
groups between double bonds as less than 1 kcal/mol (Feller et al., 2002), which is much 
lower than the height of the rotational barrier in saturated hydrocarbons (more than 3 
kcal/mol) (Smith and Jaffe, 1996).  Thermal motions within the DHA chain in the fluid 
phase can easily overcome a barrier of such low height.  Molecular dynamics simulation 
for a 1-stearoyl-2-docosahexaenoyl phosphatidylcholine (18:0-22:6 PC) bilayer, based 
on the empirical force field parametrized with quantum mechanical calculations of 
model compounds, demonstrated an excellent quantitative agreement between 
experiment and theory (Eldho et al., 2003; Feller et al., 2002), confirming the extreme 
conformational flexibility of DHA chains in membranes.  Therefore, the low energy 
barrier to rotational isomerization seems to more than compensate for the rigidity of 
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multiple double bonds, allowing the methylene groups between double bonds to act as 
flexible hinges of the DHA chain. 
 The presence of DHA at sn-2 position in mixed-chain phospholipids also affects 
the order parameter and molecular shape of the saturated chain in sn-1 position.  The 
electron density profiles of the bilayer and simulation results indicate that the DHA 
chain has a higher volume density near the lipid-water interface whereas the density of 
the saturated chain is higher in the bilayer center (Eldho et al., 2003).  As a result of this 
redistribution of chain density, the saturated chain has more freedom for movement and 
lower chain order parameters in the lower half of the chain (Eldho et al., 2003; Holte et 
al., 1995).  Based on these experiments and simulation, Eldho et al. proposed a model of 
18:0-22:6 PC in bilayers, in which the saturated and DHA chains adopt wedge and 
inverted wedge shapes, respectively (Eldho et al., 2003).  Notably, the removal of a 
single double bond at the 19 position from DHA to docosapentaenoic acid (22:5, n-6) 
equalizes the differences in chain distribution and order parameters seen between 
saturated and DHA chains, resulting in a more even distribution of chain densities in 
18:0-22:5 PC along the bilayer normal (Eldho et al., 2003; Holte et al., 1995).  This 
observation strongly supports the unique properties of DHA-rich membranes. 
Phase behavior 
 In saturated phospholipid membranes, acyl chains pack together quite uniformly 
in all-trans configuration in the gel state at low temperatures.  In membranes containing 
unsaturated fatty acids, steric restrictions associated with the presence of double bonds 
distort the packing, thereby reducing intra- and inter-molecular van der Waals 
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interactions.  The consequent decrease in stability results in a substantial decrease in the 
transition temperature (Tm) of the gel-to-liquid crystalline phase transition. 
The dependence of Tm on the number of double bonds in phospholipids has been 
well documented by differential scanning calorimetry and 2H-NMR studies (Coolbear et 
al., 1983; Holte et al., 1995; Niebylski and Salem, 1994).  The relationship between 
phase behavior and the number and position of acyl chain double bonds does not seem to 
be straightforward.  The common trend is that the introduction of the first double bond 
into one of the two acyl chains reduces Tm by ~60°C, playing the most important role in 
lowering Tm.  Beyond two double bonds, Tm is little affected and can even rise slightly.  
As a result, of a series of PCs containing stearic acid (18:0) at sn-1 position, the DHA-
containing PC melts at a higher temperature than the α-linolenic (α-18:3) or arachidonic 
(20:4) acid-containing species (Niebylski and Salem, 1994).  The endotherms recorded 
for these species show that the transition enthalpy (∆H) follows a similar trend.  ∆H 
decreases upon introduction of the first two double bonds, reaching a minimum (1.7 
kcal/mol) with 18:0-18:2 PC, and then increases with more double bonds to 6.1 kcal/mol 
for 18:0-22:6 PC.  It has been proposed that preferential van der Waals interactions 
between saturated sn-1 chains on neighboring molecules may be responsible for this 
greater stability of the DHA-containing gel state bilayer, possibly indicating 
heterogeneous lateral distribution.  In addition, the multi-component endotherms for 
highly unsaturated lipids suggest microclustering within membranes leading to 
heterogeneous melting. 
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Fluidity 
 Fluidity of membrane bilayers is typically determined by steady-state or time-
resolved measurements of fluorescence polarization of extrinsic fluorescent probes 
incorporated into membranes, which depends on both the rate of motion and the degree 
of order of the probe.  As the addition of acyl chain double bonds generally increases 
fluidity, membranes rich in DHA are often assumed to be exceptionally fluid. 
In studies with model membranes with a well-defined nature, where time-
resolved approaches have been applied for more sophisticated analysis, the orientation 
order of the probe decreases and probe dynamics increases with increasing unsaturation 
of the sn-2 chain.  Differences between monounsaturated and highly polyunsaturated 
(four or six double bonds) phospholipids were much larger than between disaturated and 
monounsaturated phospholipids (Mitchell and Litman, 1998a; Mitchell and Litman, 
1998b).  Moreover, lipids with two DHA chains showed a much lower orientational 
order relative to lipids that were polyunsaturated at sn-2 position only.  However, results 
from biological membranes that are compositionally heterogeneous appear quite 
complex, although membranes isolated from select tissues that are naturally enriched in 
DHA generally exhibit high fluidity (Harel and Djerassi, 1980; Miljanich et al., 1979; 
Mitchell et al., 1998; Stubbs and Smith, 1984).  Results from dietary studies on whole 
animals and cultured cells in DHA-supplemented media are contradictory, as both 
increased fluidity and no change have been reported (Stillwell and Wassall, 2003).  The 
failure to observe a DHA-associated increase in fluidity in many biological membranes 
has been attributed to the relative subtlety of the changes within membranes that are 
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already rich in unsaturated fatty acids.  The possibility that DHA-associated changes in 
fluidity may be local rather than global throughout the membranes is another 
confounding factor.  If this is the case, the effects of DHA will be less likely detectable 
by bulk measurements of membrane fluidity. 
Permeability and flip-flop 
 Numerous studies using biological and model membranes have reported that 
DHA increases membrane permeability.  DHA-containing membranes exhibited 
increased permeability to water (Huster et al., 1997), H+ (Brand et al., 1994; Stillwell et 
al., 1997), 22Na+ (Hendriks et al., 1976), 51Cr (Jenski et al., 1991; Stillwell et al., 1993), 
erythritol (Demel et al., 1972; Ehringer et al., 1990; Stillwell et al., 1993), 
carboxyfluorescein (Stillwell et al., 1993), glucose (Demel et al., 1972), or glycerol 
(Demel et al., 1972), compared with oleic acid (18:1)- or α-linolenic acid (α-18:3)-
containing membranes or as a function of DHA content.  In addition, dietary DHA or 
incubation with DHA has been reported to render L1210 leukemia cells grown in 
animals or in culture more permeable to the anticancer drugs mitoxantrone and 
doxorubicin (Burns et al., 1988; Burns and Spector, 1990; Spector and Burns, 1987), 
which are known to cross lipid bilayers by simple diffusion (Burns et al., 1987; Dalmark 
and Hoffmann, 1983; Decorti et al., 1998). 
The polyunsaturated DHA chain is less hydrophobic than saturated and 
monounsaturated chains, lowering cohesiveness of bilayers.  Consistent with the 
increased water permeability, DHA also increases packing free volume (ƒv) measured by 
fluorescence lifetime of membrane probe 1,6-diphenylhexatriene (DPH) (Mitchell and 
 
 29
Litman, 1998a).  Increases in ƒv and water permeability both reflect a highly disordered 
bilayer midplane region with weak chain-chain interactions.  The wedge shape of DHA-
containing PCs, proposed by Holte et al. based on 2H NMR (Holte et al., 1995), predicts 
that looser lipid packing at the aqueous interface would result in deeper penetration of 
water and other solutes into the bilayer.  As a result, DHA would promote hydration of 
the head group and interchain region.  Indeed, measurements of fluorescence decay of 
DPH in PC vesicles confirmed that water content in the bilayer hydrocarbon region 
increases with increasing chain unsaturation, with the greatest reduction in DPH 
fluorescence lifetime seen in di-22:6 PC (Mitchell and Litman, 1998b).  In addition, 
DHA-induced looser packing, as characterized by the increased ƒv, has been directly 
correlated with the facilitated MI-to-MII conformational transition of rhodopsin within 
the lipid bilayer as measured by the equilibrium constant Keq (Mitchell et al., 1998).  
This indicates that polyunsaturated chains provide a flexible environment facilitating 
structural transitions of membrane-embedded proteins such as rhodopsin. 
 Changes in lipid packing have been predicted to influence the transbilayer 
transport of phospholipids (De Kruijff and Wirtz, 1977).  Indeed, DHA has been shown 
to promote transmembrane flip-flop of phospholipids as well as membrane permeability.  
Armstrong et al. examined the effect of PC acyl chain unsaturation on the 
transmembrane movement by monitoring dithionite quenching of fluorescent 
phospholipid probe 7-nitrobenz-2-oxa-1,3-diazol-4-yl phosphatidylethanolamine (NBD-
PE) (Armstrong et al., 2003).  The flip-flop rate of NBD-PE probes increased as a 
function of the number of double bonds in PC acyl chains, with a particularly marked 
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increase in the presence of DHA.  The reported flip-flop half-life was 11.5h, 0.29h, and 
0.086h for membranes composed of 18:0-18:1 PC, 18:0-22:6 PC, and 22:6-22:6 PC, 
respectively.  Dithionite permeability rate was also enhanced with increasing 
unsaturation in this study. 
Elastic compressibility 
 In general, the average cross-sectional molecular area of phospholipid increases 
with unsaturation and is large in the presence of DHA (Demel et al., 1972; Ghosh and 
Tinoco, 1972; Ghosh et al., 1973; Smaby et al., 1997).  In addition, membranes are more 
compressible laterally when unsaturation increases, with the effect being maximal with 
DHA (Smaby et al., 1997).  This implies a lower energy requirement to deform 
unsaturated membranes.  Measurements of lateral area compressibility under osmotic 
stress revealed that 75% of the compressibility of 18:0-22:6 PC membranes is attributed 
to the DHA chain (Koenig et al., 1997), indicating that the DHA chain is far more 
compressible laterally than the saturated counterpart.  Therefore, DHA allows for larger 
lateral changes of the lipid matrix without paying a high-energy penalty.  The low 
compressibility coefficient of DHA, which presumably facilitates structural transition of 
integral proteins, has been proposed to explain the high activity of rhodopsin in DHA-
rich membranes.  While highly compressible laterally, the chain length and the area per 
molecule of polyunsaturated membranes is less sensitive to temperature changes than 
those of saturated membranes (Holte et al., 1995; Separovic and Gawrisch, 1996), 
indicating that DHA-rich membranes may provide optimal conditions for membrane-
embedded proteins over a wider temperature range. 
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Interaction of DHA and cholesterol 
 Cholesterol is a major non-phospholipid component in biological membranes and 
strongly modulates physical properties of membrane bilayers.  It is well established that 
cholesterol has a strong ordering effect on phospholipid acyl chains in the fluid phase, 
while disrupting acyl chain packing in the organized gel state (Davis, 1993; Mitchell and 
Litman, 1998a).  This results in condensation of phospholipid monolayers and a 
reduction in enthalpy of the main gel-to-liquid crystalline phase transition and in general, 
the transition is eventually eliminated at high cholesterol concentrations (Hernandez-
Borrell and Keough, 1993).  These effects of cholesterol decrease as acyl chain 
unsaturation increases, with DHA-containing PCs far less affected than many other PCs 
(Davis, 1993; Hernandez-Borrell and Keough, 1993; Mitchell and Litman, 1998a).  In 
addition, even at concentrations above 30 mol%, cholesterol has very little effect on the 
chain packing properties of dipolyunsaturated bilayers.  In both di-20:4 PC and di-22:6 
PC, cholesterol has almost no effect on the gel-to-liquid crystalline phase transition 
(Kariel et al., 1991) and causes a minimal change in acyl chain packing (Mitchell and 
Litman, 1998a) and only a small decrease in the monolayer and bilayer in-plane 
elasticity (Smaby et al., 1997).  In general, the effect of cholesterol was more diminished 
in di-22:6 PC than in di-20:4 PC. 
 Cholesterol has been shown to reduce the MI-to-MII structural transition of 
membrane protein rhodopsin as well as the acyl chain packing in reconstituted model 
membranes, regardless of phospholipid composition (Litman and Mitchell, 1996; 
Mitchell et al., 1992; Mitchell et al., 1990).  However, DHA-containing species, both di-
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22:6 PC and 16:0-22:6 PC, showed the smallest percentage of change upon introduction 
of 30 mol% of cholesterol.  In addition, the MII rhodopsin concentration in the di-22:6 
PC/30 mol% cholesterol bilayer was higher than in any of the other cholesterol-free  
phospholipid bilayers studied.  These results demonstrate that the cholesterol effect is 
highly dependent on phospholipid unsaturation and that DHA-containing membranes are 
best able to buffer the inhibitory effects of cholesterol on the structural transition of 
integral proteins. 
 Accumulating experimental evidence has established preferential affinity of 
cholesterol for saturated over polyunsaturated chains, providing a basis for the recent 
hypothesis of a lipid-driven mechanism for lateral segregation into cholesterol-rich and -
poor microdomains (Huster et al., 1998; Mitchell and Litman, 1998a; 
Pasenkiewiczgierula et al., 1991; Zerouga et al., 1995).  Unfavorable interaction between 
cholesterol and polyunsaturated chains has been clearly demonstrated by the exclusion 
of cholesterol from dipolyunsaturated PC membranes where it is forced to directly 
contact with polyunsaturated chains.  Solubility of cholesterol is dramatically reduced in 
di-20:4 PC (~15 mol%) and in di-22:6 PC (~10 mol%), relative to 18:0-20:4 PC (~49 
mol%) and 18:0-22:6 PC (~55 mol%), respectively, leading to the precipitation of 
cholesterol from the bilayer to form cholesterol monohydrate crystals (Brzustowicz et 
al., 2002a; Brzustowicz et al., 2002b; Brzustowicz et al., 1999; Brzustowicz et al., 2000).  
Studies with a variety of other techniques including differential scanning calorimetry 
(Kariel et al., 1991), 1H NMR and nuclear Overhauser enhancement spectroscopy with 
magic angle spinning (Huster et al., 1998), determination of partition coefficients (Niu 
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and Litman, 2002), measurements of lateral compressibility (Needham and Nunn, 1990), 
and fluorescence anisotropy (Mitchell and Litman, 1998a; Mitchell and Litman, 1998b) 
offered a similar conclusion.  In general, the interaction of cholesterol with DHA was the 
weakest of all the acyl chains examined. 
 Huang and co-workers proposed the umbrella model to describe the solubility 
and condensing effect of cholesterol within membranes (Huang and Feigenson, 1999).  
According to this model, phospholipid head groups act as ‘umbrellas’ to prevent the 
energetically unfavorable contact of the non-polar part of cholesterol with interfacial 
water.  This shielding will be less effective for DHA-containing phospholipids with a 
large molecular cross-sectional area, facilitating cholesterol precipitation at a lower 
concentration.  In addition, this model allows for speculation that 
phosphatidylethanolamine (PE) with a smaller head group may enhance the DHA-
associated reduction in shielding effects relative to PC.  Consistent with this notion, 
unlike PC bilayers where a marked reduction in cholesterol solubility requires 
polyunsaturation at both sn-1 and sn-2 positions, DHA at sn-2 position with a saturated 
sn-1 chain is sufficient in PE to trigger cholesterol precipitation (Shaikh et al., 2003).  
The preferential interaction of cholesterol with 18:0-22:6 PC over 18: 22:6 PE and 18:0-
22:6 phosphatidylserine (PS) and the larger increase in cholesterol-induced order in 
18:0-22:6 PC in 18:0-22:6 PC/PE/PS/cholesterol mixture may be explained in a similar 
manner (Huster et al., 1998). 
 Cholesterol-dependent molecular sorting of membrane lipids based on the 
differential ordering of saturated versus polyunsaturated chains has provided an 
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important basis for the mechanism responsible for the heterogeneous lateral organization 
in membranes.  Although support from biological membranes has not been clear, 
growing evidence from model membrane studies suggest that the energetically less 
favorable interaction between cholesterol and PUFAs, especially DHA, promotes lateral 
phase segregation into sterol-poor/PUFA-rich and sterol-rich/saturated fatty acid-rich 
microdomains (Brzustowicz et al., 2002a; Brzustowicz et al., 2002b; Huster et al., 1998; 
Mitchell and Litman, 1998a; Niu and Litman, 2002; Pasenkiewicz-Gierula et al., 1990).  
With regard to the molecular organization inside cholesterol/saturated acyl chain 
microdomains, Mitchell and Litman (Mitchell and Litman, 1998a) proposed a model of 
transient, highly dynamic microdomains.  They envisaged that cholesterol is surrounded 
by mixed-chain saturated-polyunsaturated PCs with their saturated sn-1chains pointing 
toward the tightly packed interior of the domain and the polyunsaturated sn-2 chains 
oriented toward the domain boundary.  A similar model was proposed by Huster et al. 
(Huster et al., 1998).  Notably, fluorescence resonance energy transfer experiments have 
provided evidence of the formation of lateral domains in a mixed PC system composed 
of di-22:6 PC, di-16:0 PC, cholesterol, and rhodopsin (Polozova and Litman, 2000).  In 
this study, rhodopsin preferentially segregated with di-22:6 PC, while cholesterol with 
di-16:0 PC.  Lateral domain behavior was observed only when both cholesterol and 
rhodopsin were present in the bilayers.  The results of this study predict similar local 
compositional behavior for other proteins with a preference for a DHA-rich 
microenvironment. 
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CHAPTER III 
MATERIALS AND METHODS 
 
Reagents and plasmids 
RPMI 1640 was obtained from Mediatech (Herndon, VA).  Leibovitz’s L-15 was 
purchased from Invitrogen (Carlsbad, CA).  Fetal bovine serum (FBS) was from 
Hyclone (Logan, UT).  Insulin/transferrin/selenium (ITS) was purchased from 
Collaborative Biomedical Products (Bedford, MA).  GlutaMAX-1 and recombinant 
mouse interferon-γ (IFN-γ) were obtained from Gibco BRL (Grand Island, NY).  Fatty 
acid-free bovine serum albumin (BSA) and mycoplasma PCR-based ELISA were from 
Roche (Indianapolis, IN).  Fatty acids were purchased from NuChek Prep (Elysian, 
MN).  FM 4-64, BODIPY-TR ceramide, and Live/Dead Viability/Toxicity kit were from 
Molecular Probes (Eugene, OR).  Effectene Transfection Reagent was purchased from 
Qiagen (Valencia, CA).  LipofectAMINE 2000 was obtained from Life Technologies 
(Rockville, MD).  All other reagents and tissue culture wares were from Fisher Scientific 
(Fair Lawn, NJ). 
An expression vector encoding GFP fused with wild-type N-Ras (GFP-Nras-wt) 
in pEGFP-C3 (Clontech, Palo Alto, CA) was a kind gift from Dr. Mark Philips (New 
York University, New York, NY).  Expression vectors for GFP-tagged wild-type or 
oncogenic forms of H-Ras and K-Ras4B (GFP-Hras-wt, GFP-HrasG12V, GFP-Kras-wt, 
and GFP-KrasG12V, respectively) in pEGFP-C3 were kindly provided by Dr. John 
Hancock (University of Queensland, Queensland, Australia).  Expression vectors 
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encoding GFP extended with C-terminal 9 amino acids of H-Ras or C-terminal 17 amino 
acids of K-Ras4B (GFP-tH and GFP-tK, respectively) were also gifts from Dr. John 
Hancock.  GFP fusion constructs of full-length Lck or Fyn (Lck-GFP and Fyn-GFP, 
respectively) in pEGFP-N1 (Clontech) were generously provided by Dr. Mark Davis 
(Stanford University, Stanford, CA) and Dr. Marilyn Resh (Memorial Sloan-Kettering 
Cancer Center, New York, NY), respectively.  The GFP fusion construct of the ts045 
temperature-sensitive mutant of vesicular stomatitis virus glycoprotein, VSVG (VSVG3-
GFP; referred to VSVG-GFP in this manuscript), was a kind gift from Dr. Kai Simons 
(Max Planck Institute, Dresden, Germany). 
 
Cell culture and transfection 
Young adult mouse colon (YAMC) cells were kindly donated by Dr. Robert Whitehead 
(Ludwig Institute for Cancer Research, Melbourne, Australia).  YAMC cells are normal 
murine colonic epithelial cells derived from the H-2kb-tsA58 transgenic Immortomouse 
and are conditionally immortalized by a temperature-sensitive mutant of the simian virus 
40 large T antigen (tsA58) under the control of IFN-γ-inducible H-2kb promoter 
(Whitehead et al., 1993).  YAMC cells (passages 16-20) were maintained in RPMI 1640 
supplemented with 5% FBS, 2 mM GlutaMax-1 (L-alanyl-L-glutamine), ITS (5 µg/ml 
insulin; 5 µg/ml transferrin; 5 ng/ml selenious acid), and 5 IU/ml of murine IFN-γ under 
permissive conditions at 33°C in a humidified incubator with 5% CO2.  When VSVG-
GFP was expressed, cells were maintained at the permissive temperature for VSVG 
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transport, 32°C (Bergmann, 1989).  Cultures were routinely confirmed to be 
mycoplasma free using a PCR-based ELISA. 
For transient transfection, YAMC cells were grown on Lab-Tek 2-well glass 
coverslips (Nalge Nunc, Rochester, NY) and were transfected for 3h using Effectene 
(0.2 µg DNA per well for GFP-tagged Ras, GFP-tH, and GFP-tK) or LipofectAMINE 
2000 (1.5-2.0 µg DNA per well for Lck-GFP, Fyn-GFP, and VSVG-GFP) according to 
the manufacturers’ instructions.  All transfection conditions were optimized to minimize 
the amounts of DNA and lipofection reagent and the length of incubation time in order 
to prevent any non-specific cytotoxicity. 
 
Preparation of fatty acid-albumin complex 
Free fatty acids in ethanol were stored at −80°C under nitrogen.  Fatty acid-BSA 
complexes were prepared by modification of the method described by Lynch (Lynch, 
1980).  Briefly, aliquots of fatty acids in ethanol were dried under nitrogen and then 
dissolved in 50 mM sodium carbonate.  Next, fatty acid-free BSA (15%) in RPMI 1640 
medium was added to fatty acid sodium salts to give a final fatty acid concentration of 
2.5 mM and a fatty acid to albumin molar ratio of 3:1.  Aliquots of 0.2 µm filter-
sterilized fatty acid-BSA complexes were stored at −20°C and were used within one 
month after preparation. 
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Confocal microscopy 
Cells were plated onto two-well glass coverslips at a density of 5-20 × 103 cells per well.  
Next day, fatty acid treatment with 50 µM BSA-bound DHA, LA, or oleic acid (OA) 
initiated 24h prior to transfection and continued until live cells were examined 36-48h 
post-transfection using confocal laser scanning microscopy.  Where indicated, cells 
incubated with DHA were washed three times with phosphate-buffered saline 36h after 
transfection and were subsequently placed in LA- or OA-supplemented medium and 
imaged 24h later.  Medium supplemented with fatty acids was replenished every 24h.  
Transient transfection was performed in the absence of fatty acids for 3h and cells were 
subsequently returned to fatty acid-supplemented medium.  The experimental time 
course is summarized in Fig. 4.  Images were collected using a Radiance 2000 MP 
confocal microscope equipped with a LaserSharp 2000 acquisition software (BioRad, 
Hercules, CA).  Cells were stained with a vital fluorescent dye FM 4-64 (20 µM) in cold 
Leibovitz’s L-15 medium without phenol red to visualize the PM (Janecki et al., 2000).  
The low temperature was used to prevent endocytosis of FM 4-64 and to arrest 
intracellular vesicle traffic during optical scanning (Kuismanen and Saraste, 1989).  
Immediately after staining, confocal z-serial images across the entire cell were obtained 
with a 0.8 µm optical section thickness using a 60×, numerical aperture (N.A.) 1.2 water 
immersion objective.  For cells expressing GFP-Nras-wt, a 40×, N.A. 1.3 oil immersion 
objective and 0.7 µm intervals in the z axis were used.  In general, 9-10 optical sections 
were required to scan the entire cell, corresponding to approximately 7-8 µm of cell 
thickness.  GFP and FM 4-64 were excited at 488 nm and 568 nm, respectively, and 
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igure 4.  Summarized experimental time course.  YAMC cells were plated onto glass 
coverslips and were incubated with 50 µM albumin-bound DHA, LA, or OA for 24h 
~ 72 h treatment with 50 µM fatty acid-BSA complex
Day 0         1                    2      3     4
Seeding Transfection Imaging
at 36-48 h
post-transfection
 
 
F
prior to and 36-48h after transfection.  Live cells transiently expressing GFP-labeled 
proteins were examined two days post-transfection using confocal microscopy. 
 
  
40
emitted fluorescence was collected simultaneously by two separate photomultipliers 
using 515 ± 15 nm bandpass filter (GFP) and 600 nm longpass filter (FM 4-64).  After 
image acquisition, cell viability was examined using a Live/Dead Viability/Toxicity kit.  
Cell viability was greater than 90% in all dishes.  An example of z-serial image stacks 
obtained from a GFP-Hras-wt-expressing YAMC cell with FM 4-64 staining is shown in 
Fig. 5. 
 
Quantification of subcellular localization of GFP-labeled proteins 
The z-series stack images were digitally processed using MetaMorph software 
(Universal Imaging Corp., West Chester, PA) to quantify the localization of GFP-labeled 
proteins at the PM and at the Golgi.  The relative amount of GFP-labeled proteins 
associated with the PM or with the Golgi was expressed as a percentage of total cellular 
GFP-labeled proteins.  Fig. 6 illustrates analytical principles of the quantification of the 
PM- and Golgi-localized GFP-labeled proteins. 
The PM localization of GFP-labeled proteins was quantified using the 
morphometric method described by Janecki (Janecki et al., 2000) with modifications as 
follows.  First, the optical sections spanning the entire cell were selected from the 
original image stack for analysis.  The optical section corresponding to the bottom of the 
cell, which contains the basal membrane facing the culture substratum, was identified 
based on the high intensity GFP and FM 4-64 fluorescence signals homogeneously 
distributed across the entire cell area.  The images of FM 4-64 representing the PM were 
thresholded, binarized and inverted to generate binary masks of the PM.  Next, the 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.  Confocal serial optical sections of a living YAMC cell stained with FM 4-64.  YAMC cells expressing GFP-
labeled proteins were incubated with a vital styryl dye FM 4-64 (20 µM) on a microscopic stage.  Signals from GFP (green) 
and FM 4-64 (red) were collected by separate photomultipliers.  Confocal z-serial optical sections collected from the bottom 
towards the top of the cell (A-L) in steps of 0.8 µm are shown as overlay images of green and red fluorescence signals.  
Yellow or orange regions indicate colocalization of GFP and FM 4-64 signals.  Scale bar represents 10 µm.  41
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Figure 6.  Analytical procedure to quantify the relative subcellular localization of GFP-labeled proteins.  (A) 
Background-subtracted GFP image.  Fluorescence signals from FM 4-64 illuminating the PM (B) were converted to a binary 
mask of the PM (C).  A logical operation of “AND” was performed on the background-subtracted GFP image (A) and the 
binary mask of the PM (C), which resulted in a digital subtraction of GFP signals from the PM region (D).  This procedure was 
performed on all optical sections spanning the entire cell.  Next, z-serial stacks of the background-subtracted original GFP 
images and the new digitally processed GFP images lacking the signal at the PM were individually summed into single images 
(E and F, respectively).  In E and F, fluorescence intensities are color-coded based on the pseudocolor scale (inset in F).  Areas 
enclosed by pink lines in E and F are the region of interest (ROI) used to define the entire cell area, from which the integrated 
fluorescence intensities of total cellular (Ft) and total intracellular GFP-labeled proteins (Fi) were obtained respectively.  The 
black line in E marks the ROI corresponding to the Golgi, from which the integrated fluorescence intensity of Golgi-localized 
GFP-labeled proteins (Fg) was obtained.  The percentages of the PM- and Golgi-localized GFP-labeled proteins were 
calculated using formulae [(Ft − Fi)/Ft] × 100 and (Fg/Ft) × 100, respectively.  Scale bar represents 10 µm. 
 
 
 43
Boolean logical operation “AND” was performed on the pair of the background-
subtracted GFP image stack and the binary mask image stack.  The result of this 
operation was a new z-series of GFP images in which the GFP signal at the PM was 
digitally subtracted.  Then, using “Sum of” stack arithmetic operation, the background-
subtracted original and the new processed series of GFP images were individually 
summed into single images, from which the integrated fluorescence intensities of total 
cellular (Ft) and total intracellular GFP-labeled proteins (Fi) were obtained, respectively.  
The final calculation of the percentage of PM-localized GFP-labeled proteins was 
conducted using a formula [(Ft − Fi)/Ft] × 100. 
Alternatively, in an attempt to semi-automate the above-mentioned analytical 
procedure to quantify the relative PM localization, an algorithm with a graphical 
interface was developed using the SDC Morphology Toolbox V1.1 for MATLAB 
Version 6.1.0.450 (R12.1).  The numerical values calculated using the algorithm were 
highly comparable to the manually calculated data using MetaMorph software for the 
same cell and the difference between the two measurements was statistically 
insignificant. 
The percentage of GFP-Nras-wt, GFP-Hras-wt or GFP-HrasG12V localized at 
the Golgi was calculated using the single image generated by “Sum of” stack arithmetic 
operation on the background-subtracted GFP image stack.  The region of interest (ROI) 
corresponding to the Golgi was determined based on the perinuclear cytological 
positioning and the distinct condensed tubulovesicular morphology well delineated by 
intense GFP-Ras fluorescence. 
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Images were processed using Adobe Photoshop 7.0 (Adobe Systems, San Jose, 
CA) for presentation. 
 
Statistical analysis 
To examine how the PM localization of GFP-labeled proteins varied with different fatty 
acid treatment, t- and F-tests under linear mixed-effects models (Pinheiro and Bates, 
2000) were performed.  Since the measurements were done either manually with 
MetaMorph software and/or using the automatic algorithm, there was a need to account 
for the discrepancy between the two measuring methods.  Therefore, under the 
assumption that either a constant shift or a linear model was held between these two 
types of measurements, a comprehensive mixed effects model was constructed using 
sub-components to accommodate the general relationships among these two types of 
measurement methods and different fatty acid treatments.  Cell level random effects 
were used to model the dependency between measurements taken from the same cell by 
two different measurement methods.  Considering that the main interest was on the fatty 
acid effects, instead of estimating the unknown shift or regression coefficients in the 
sub-component that linked the two types of measurements and then using them in the 
estimation of the fatty acid effects under one of the two measuring methods, the 
unknown parameters were re-parametrized so that a direct estimation of fatty acid effects 
became feasible.  Under this re-parametrization, the best linear unbiased predictions of 
the average fatty acid effects using both methods with the same sample sizes could be 
obtained.  This direct approach has an advantage of less estimation variation and 
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consequently a higher power compared to implementing a multi-stage estimation 
method.  Pairwise t-tests accounting for the mixed effects model variation were then 
carried out to compare the fatty acid treatments. 
To determine fatty acid effects on the Golgi localization of GFP-labeled proteins, 
the statistical significance of differences among means was analyzed using one-way 
ANOVA and pairwise t-tests. 
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CHAPTER IV 
RESULTS 
 
DHA alters PM targeting and subcellular distribution of GFP-Nras-wt 
Ras targeting to the inner surface of the PM, the main Ras signaling platform, remains 
crucial for its physiological and oncogenic activities, although recent findings revealed 
that Ras can engage signaling pathways even in the intracellular membrane 
compartments (Arozarena et al., 2004; Bivona et al., 2003; Caloca et al., 2003; Chiu et 
al., 2002; Jiang and Sorkin, 2002; Perez de Castro et al., 2004).  To determine whether 
the PM localization of Ras is altered by fatty acid treatment, YAMC cells transiently 
overexpressing GFP-Nras-wt were incubated with a physiological dose (50 µM) 
(Conquer and Holub, 1998) of DHA (22:6, n-3) or LA (18:2, n-6) and were examined 
alive using three-dimensional confocal microscopy 36-48h post-transfection.  For 
accurate quantification of PM-associated GFP-Nras-wt, a lipophilic, membrane-
impermeable fluorophore, FM 4-64, was used to specifically label the PM (Janecki et al., 
2000).  The effects of DHA and LA were examined because DHA present in fish oil has 
previously been shown to decrease Ras membrane association as well as Ras-dependent 
signaling relative to LA, the major dietary PUFA in the U.S. diet (Collett et al., 2001).  
Untreated cells were used as a negative control to account for any non-specific effects of 
fatty acid supplementation on the subcellular distribution of GFP-Nras-wt.  Cell viability 
measured after image acquisition was greater than 90% in all treatment groups, 
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indicating that neither fatty acid treatment nor fluorescence imaging caused non-specific 
cellular toxicity. 
 In agreement with previous reports on GFP-Nras subcellular localization (Choy 
et al., 1999), GFP-Nras-wt expression was evident at the PM and endomembrane 
structures in YAMC cells, with the most prominent feature being the intense GFP 
fluorescence delineating a compact perinuclear structure, presumably the Golgi (Fig. 7).  
The perinuclear structure was confirmed as the Golgi by colocalization with a Golgi-
specific vital dye, BODIPY-TR ceramide (Pagano et al., 1991).  As illustrated by 
representative images in Fig. 7, while untreated and LA-treated cells shared a similar 
subcellular distribution of GFP-Nras-wt with substantial PM staining, the distribution 
pattern was strikingly different in DHA-treated cells, displaying very little PM 
fluorescence and predominant localization of GFP-Nras-wt at the endomembrane 
compartments with extensive staining at the Golgi.  These contrasting distributions were 
also evident in axial z sections cutting through the nucleus and the Golgi region (Fig. 7 
insets).  Cells with varying total cellular fluorescence intensities from six repeated 
experiments showed a very similar distribution pattern of GFP-Nras-wt within the same 
treatment group, indicating that 1) the expression level of GFP fusion proteins does not 
affect their intracellular trafficking and localization under the defined experimental 
conditions, and 2) the predominant association of GFP-Nras-wt with the endomembrane 
structures in DHA-treated cells is not due to differences in the protein expression level.  
In order to quantitatively compare the fatty acid effects on the subcellular localization of 
GFP-Nras-wt in YAMC cells, the percentage of GFP-Nras-wt localized at the PM and
48
 
 
 
 
 
 
 
 
 
 
 
Figure 7.  DHA alters the subcellular distribution of GFP-Nras-wt.  YAMC cells were incubated with 50 µM LA, or DHA 
or left untreated for 24h prior to transfection with pGFP-Nras-wt.  Cells were further incubated with fatty acids or left 
untreated until live cells were examined by confocal microscopy 36-48h after transfection.  Representative confocal enface 
sections of untreated and LA- or DHA-treated cells are shown.  Insets in each panel depict reconstructed axial z sections 
cutting through the nucleus and the Golgi region of the same cell.  Note the prominent GFP illumination of endomembrane 
structures in DHA-treated cells.  Arrows and N mark perinuclear Golgi structures and nuclei, respectively.  Scale bar 
represents 10 µm. 
Untreated LA
N
N
N 
DHA
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the Golgi was quantified using digital image processing (Fig. 8).  Unlike the ER, the area 
corresponding to the Golgi was readily identifiable due to the distinct compact 
multivesicular morphology and perinuclear positioning illuminated by intense GFP 
fluorescence.  Therefore, meaningful quantification of the Golgi-localized GFP-Nras-wt 
was feasible within this experimental setup although it should be noted that the measured 
Golgi fluorescence intensity contained small contributions from fractions of the ER and 
the PM that overlap the Golgi ROI (Fig. 6).  PM localization of GFP-Nras-wt (% of GFP 
fluorescence at the PM relative to the total cellular GFP fluorescence) in LA-treated cells 
(21.2 ± 0.8%; mean ± SE) was slightly higher than that of untreated cells (16.8 ± 1.8%) 
but there was no significant difference in the Golgi association (15.7 ± 1.6% and 12.9 ± 
2.4%, respectively).  In contrast, DHA treatment markedly reduced PM-localized GFP-
Nras-wt (9.3 ± 0.7%) by 56% and 44% compared with LA and no treatment 
respectively, while significantly increasing the Golgi localization (23.0 ± 1.6%) by 55% 
compared with both LA and no treatment (14.9 ± 1.3%; pooled from untreated and LA-
treated cells), consistent with the qualitative observation of the increased endomembrane 
association at the expense of PM expression.  A total of 50 cells with varying expression 
levels of GFP-Nras-wt (integrated total cellular fluorescence intensities of 6.5 × 105-1.5 
× 107 or average pixel intensities of 13-850) were analyzed and no statistical relationship 
was found between total cellular fluorescence intensities and the relative PM or Golgi 
localization, confirming that the subcellular targeting of GFP-Nras-wt was largely 
independent of its protein expression level.  In addition, this indicates that the secretory 
50
 
 
 
 
 
Figure 8.  DHA decreases PM localization and increases Golgi association of GFP-Nras-wt.  YAMC cells were incubated 
with 50 µM LA, or DHA or left untreated for 24h prior to and 36-48h after transfection with pGFP-Nras-wt.  Cells were 
stained with a vital dye FM 4-64 on a microscopic stage and z-serial images of living cells expressing GFP-Nras-wt were 
obtained by confocal microscopy 36-48h post-transfection.  The relative amount of GFP-Nras-wt localized at the PM or at the 
Golgi was quantified as percent of total cellular GFP-Nras-wt as described in Materials and Methods.  (A) Relative PM 
localization of GFP-Nras-wt.  (B) Relative Golgi localization of GFP-Nras-wt.  A total of 50 cells from 6 independent 
experiments were analyzed and data are presented as mean ± SE.  Different letters denote statistical significance at p < 0.007 
for (A) and at p < 0.003 for (B), respectively. 
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transport machinery or rate-limiting steps therein was not saturated by the 
overexpression of GFP fusion proteins under the defined experimental conditions. 
 
DHA alters intracellular trafficking of GFP-Hras but not GFP-Kras to the PM 
regardless of their mutation status 
Ras isoforms, H-Ras, N-Ras, and K-Ras4B, utilize different membrane anchors and 
trafficking routes to the PM.  Upon completion of the common sequential post-
translational processing driven by a CAAX motif on the cytoplasmic surface of the ER, 
Ras isoforms take different trafficking routes to transit to the PM.  H- and N-Ras are 
additionally palmitoylated on one (N-Ras) or two (H-Ras) cysteine residue(s) adjacent to 
the C-terminal CAAX motif and traffic to the PM along the exocytic pathway via 
vesicular transport through the Golgi.  In contrast, K-Ras4B containing a polybasic 
region of six contiguous lysine residues takes an as yet undefined pathway to the PM 
that bypasses the Golgi (Apolloni et al., 2000; Choy et al., 1999).  Therefore, it was 
investigated whether DHA exerts the same effects on the PM targeting of GFP-labeled 
H-Ras and K-Ras4B as it does on GFP-Nras-wt.  Because the similar distribution pattern 
of GFP-Nras-wt between untreated and LA-treated YAMC cells indicated that fatty acid 
supplementation per se does not cause significant alterations in subcellular targeting of 
GFP-labeled proteins, the effects of DHA were compared with other common dietary 
unsaturated fatty acids, LA and OA.  LA (18:2, n-6) is the predominant dietary PUFA in 
Western diets (Baghurst et al., 1988; Mann et al., 1995; Okuyama et al., 1996) and the 
major fatty acid in most vegetable oils.  OA (18:1, n-9) is highly prevalent in the 
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Mediterranean diet and enriched in olive oil.  Dietary consumption of DHA, LA, or OA 
readily alters cellular lipid environment by incorporation into membrane phospholipids 
(Glatz et al., 1989; Katan et al., 1997; Pagnan et al., 1989; Vidgren et al., 1997).  
Illustrated in Fig. 9 are representative images of GFP-Hras-wt-expressing cells incubated 
with fatty acids.  Whereas the overall subcellular localization of GFP-H-Ras-wt was 
similar to that of GFP-Nras-wt in terms of the PM, Golgi, and ER expression, as 
previously reported (Choy et al., 1999), some quantitative differences were apparent.  
GFP-Hras-wt-expressing cells had much more prominent PM fluorescence and less 
intense Golgi staining compared with GFP-Nras-wt in all fatty acid treatment groups.  
The subcellular distribution of GFP-Hras-wt was indistinguishable between LA- and 
OA-treated cells, as confirmed by no difference in either PM- or Golgi-associated 
fractions (Fig. 10).  DHA, however, significantly reduced the PM localization (37.7 ± 
1.5%) of GFP-Hras-wt by 36% and increased the endomembrane association as 
evidenced by 56% increase in the Golgi localization (10.4 ± 1.3%), compared with LA 
and OA (59.1 ± 1.2% at the PM and 6.6 ± 0.5% at the Golgi; pooled values from LA- 
and OA-treated cells).  GFP-Kras-wt was expressed at the PM along with a rather diffuse 
staining over the cytoplasm occasionally in a punctate manner, suggestive of ER 
association (Fig. 11).  As expected, there was no particular intense GFP fluorescence 
illuminating any distinct perinuclear vesicular structure.  Interestingly, unlike 
palmitoylated H- and N-Ras with the same trafficking route to the PM, the relative PM 
expression as well as distribution pattern of GFP-Kras-wt was unaffected by fatty acid 
treatment (Fig. 11 and Fig. 12).  The magnitude of PM localization of GFP-Kras-wt 
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Figure 9.  DHA alters the subcellular distribution of GFP-Hras-wt.  YAMC cells were incubated with 50 µM OA, LA, or 
DHA for 24h prior to transfection with pGFP-Hras-wt.  Cells were further incubated with fatty acids until live cells were 
examined by confocal microscopy 36-48h after transfection.  Representative confocal enface sections of OA-, LA-, or DHA-
treated cells are shown.  Insets in each panel depict reconstructed axial z sections cutting through the nucleus and the Golgi 
region of the same cell.  Note the prominent GFP illumination of endomembrane structures in DHA-treated cells.  Arrows and 
N mark perinuclear Golgi structures and nuclei, respectively.  Scale bar represents 10 µm. 
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Figure 10.  DHA decreases PM localization and increases Golgi association of GFP-Hras-wt.  YAMC cells were incubated 
with 50 µM OA, LA, or DHA for 24h prior to and 36-48h after transfection with pGFP-Hras-wt.  Cells were stained with a 
vital dye FM 4-64 on a microscopic stage and z-serial images of living cells expressing GFP-Hras-wt were obtained by 
confocal microscopy 36-48h post-transfection.  The relative amount of GFP-Hras-wt localized at the PM or at the Golgi was 
quantified as percent of total cellular GFP-Hras-wt as described in Materials and Methods.  (A) Relative PM localization of 
GFP-Hras-wt.  (B) Relative Golgi localization of GFP-Hras-wt.  A total of 33 cells from 2 independent experiments were 
analyzed and data are presented as mean ± SE.  Different letters denote statistical significance at p < 0.0001 for (A) and at p < 
0.02 for (B), respectively. 
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Figure 11.  Subcellular distribution of GFP-Kras-wt is not altered by fatty acid treatment.  YAMC cells were incubated 
with 50 µM OA, LA, or DHA for 24h prior to transfection with pGFP-Kras-wt.  Cells were further incubated with fatty acids 
until live cells were examined by confocal microscopy 36-48h after transfection.  Representative confocal enface sections of 
OA-, LA-, or DHA-treated cells are shown.  Insets in each panel depict reconstructed axial z sections cutting through the 
nucleus of the same cell.  Nuclei are marked with N.  Scale bar represents 10 µm. 
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Figure 12.  PM localization of GFP-Kras-wt is not al acid treatment.  
YAMC cells were incubated with 50 µM OA, LA, or DHA for 24h prior to and 36-48h 
after transfection with pGFP-Kras-wt.  Cells were stained with a vital dye FM 4-64 on a 
microscopic stage and z-serial images of living cells P-Kras-wt were 
obtained by confocal microscopy 36-48h post-transfectio amount of GFP-
Kras-wt localized at the PM was quantified as percent o GFP-Kras-wt as 
described in Materials and Methods.  A total of 30 cells from 2 independent experiments 
were analyzed and data are presented as mean ± SE.  
observed among means (p > 0.58). 
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(44.5 ± 2.3%) was less than that of GFP-Hras-wt (59.1 ± 1.2% in LA- and OA-treated 
ells) but greater than that of N-Ras-wt (16.8 ± 1.8%, and 21.2 ± 0.8% in untreated and 
A-treated cells, respectively). 
As oncogenic Ras proteins carrying a point mutation at either codon 12, 13, or 61 
play a major role in numerous human malignancies (Bos, 1989; Campbell and Der, 
olecular 
 association has 
2000; W  
alte  of 
RasG12V was dete orms, 
while DHA treatment dramatically altered the subcellular localization of GFP-
HrasG12V compared with LA and OA (Fig. 13 and Fig. 14), there was no difference 
 reflecting an increased endomembrane association, 
compared with LA and OA (62.0 ± 1.8% at the PM and 8.1 ± 0.7% at the Golgi; pooled 
values from LA- and OA-treated cells) (Fig. 14).  However, in GFP-HrasG12V-
expressing cells treated with DHA, the overall endomembrane staining often seemed
c
L
2004), Ras itself and Ras-dependent signaling pathways have been important m
targets for anticancer therapies.  Among others, inhibition of Ras PM
been the major approach to develop Ras-directed anticancer agents (Kloog and Cox, 
ittinghofer and Waldmann, 2000).  In light of DHA-induced differential
rations in the PM targeting of wild-type Ras isoforms tagged with GFP, the ability
DHA to alter the PM localization of GFP-labeled oncogenic H-RasG12V and K-
rmined.  In parallel with the results from wild-type Ras isof
among fatty acid-treated cells with regard to PM localization and distribution of GFP-
KrasG12V (Fig. 15 and Fig. 16).  Quantitatively, the extent of the DHA effect on GFP-
HrasG12V was similar to its wild-type version in that DHA caused suppression of GFP-
HrasG12V localization at the PM (41.9 ± 2.4%) by 32%, concomitant with 85% increase 
in the Golgi fraction (14.9 ± 3.1%)
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e statistical significance at p < 0.0001 
for (A) and at p < 0.04 for (B), respectively. 
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Figure 14.  DHA decreases PM localization and increases Golgi association of GFP-HrasG12V.  YAMC cells were 
incubated with 50 µM OA, LA, or DHA for 24h prior to and 36-48h after transfection with pGFP-HrasG12V.  Cells were 
stained with a vital dye FM 4-64 on a microscopic stage and z-serial images of living cells expressing GFP-Hras-G12V were 
obtained by confocal microscopy 36-48h post-transfection.  The relative amount of GFP-HrasG12V localized at the PM or at 
the Golgi was quantified as percent of total cellular GFP-HrasG12V as described in Materials and Methods.  (A) Relative PM 
localization of GFP-HrasG12V.  (B) Relative Golgi localization of GFP-HrasG12V.  A total of 35 cells from 2 independent 
xperiments were analyzed and data are presented as mean ± SE.  Different letters denote
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Figure 15.  Subcellular distribution of GFP-KrasG12V is not altered by fatty acid treatment.  YAMC cells were 
incubated with 50 µM OA, LA, or DHA for 24h prior to transfection with pGFP-KrasG12V.  Cells were further incubated with 
fatty acids until live cells were examined by confocal microscopy 36-48h after transfection.  Representative confocal enface 
sections of OA-, LA-, or DHA-treated cells are shown.  Insets in each panel depict reconstructed axial z sections cutting 
through the nucleus of the same cell.  Nuclei are marked with N.  Scale bar represents 10 µm. 
 
 
 
 61
 
 
 
 
 
 
Figure 16.  PM localization of GFP-KrasG12V is not a acid treatment.  
YAMC cells were incubated with 50 µM OA, LA, or DHA for 24h prior to and 36-48h 
after transfection with pGFP-KrasG12V.  Cells were stained with a vital dye FM 4-64 on 
a microscopic stage and z-serial images of living cells expressing GFP-KrasG12V were 
obtained by confocal microscopy 36-48h post-transfectio amount of GFP-
KrasG12V localized at the PM was quantified as p  cellular GFP-
KrasG12V as described in Materials and Methods.  A total of 57 cells from 6 
independent experiments were analyzed and data are ean ± SE.  No 
significant difference was observed among means (p > 0
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more concentrated around the juxtanuclear region rather then the cell periphery (Fig. 13) 
ompared with the more spread and diffuse endomembrane illumination by GFP-labeled 
ild-type N-Ras and H-Ras in DHA-treated cells (Fig. 7 and Fig. 9).  Similarly, GFP 
uorescence reported a more prominent and concentrated endomembrane association of 
oncogenic K-Ras relative to wild-type K-Ras in all fatty acid-treated cells (Fig. 11 and 
ltivesicular Golgi 
 differences exist in 
the subce
 
the subcellu
me embrane 
ssociation of GFP-labeled N-Ras and H-Ras but not K-Ras, regardless of their mutation 
tatus. 
 et al., 2003).  GFP-labeled 
full-length Ras isoforms are biologically functional.  They recruit and activate 
downstream effectors upon upstream stimulation and oncogenic forms retain 
transforming activity (Niv et al., 1999; Niv et al., 2002; Perez de Castro et al., 2004).  
Therefore, DHA-induced differential alterations in PM targeting of Ras isoforms may be 
c
w
fl
Fig. 15), although intense GFP fluorescence signifying the compact mu
structure was absent in both.  These observations suggest that subtle
llular localization between wild-type and oncogenic Ras proteins. 
Taken together, these findings clearly demonstrate that DHA differentially alters 
lar localization of Ras isoforms depending on their trafficking routes and/or 
mbrane anchors, thereby decreasing PM localization and increasing endom
a
s
 
DHA-induced alterations in Ras trafficking are independent of Ras signaling 
Ras downstream signaling pathways can affect membrane traffic directly and indirectly 
by modulating regulators of vesicular traffic and cytoskeleton dynamics (Babia et al., 
1999; Lanzetti et al., 2001; Ridley, 2001; Tall et al., 2001; Xu
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attributed to the interference with the isoform-specific signaling functions of 
overexpressed Ras.  To test this hypothesis, the effect of DHA on the ability of isolated 
H- and K-Ras targeting sequences to direct GFP to the PM was examined.  GFP-tH and 
GFP-tK are biologically inert GFP chimeras, which are extended at the C-terminus with 
the last 9 amino acids of H-Ras and the last 17 amino acids of K-Ras4B, respectively.  
These extensively characterized GFP fusion proteins retain the trafficking characteristics 
and localization pattern of their cognate full-length Ras isoforms, due to the presence of 
Ras C-terminal sequences containing all the necessary and sufficient information for PM 
to that of GFP-labeled wild-type H-Ras (Fig. 9) rather than oncogenic H-Ras in 
HA-treated cells (Fig. 13).  When the effect of DHA on GFP-tH PM targeting was 
ecame 
targeting (Apolloni et al., 2000; Choy et al., 1999; Prior et al., 2001). 
As shown in Fig. 17 and Fig. 18, DHA treatment, compared with LA and OA, 
significantly reduced PM localization by 40% and increased the endomembrane pool of 
GFP-tH.  The endomembrane staining pattern of GFP-tH in DHA-treated cells was very 
similar 
D
compared with GFP-labeled full-length wild-type and oncogenic H-Ras, it b
apparent that the relative PM localization in DHA-treated cells (36.1 ± 1.7%, 37.7 ± 
1.5%, and 41.9 ± 2.4%, respectively) as well as the extent of DHA-induced decrease in 
PM targeting (by 40%, 36%, and 32%, respectively, relative to values pooled from LA- 
and OA-treated cells) was remarkably similar among all three constructs, indicating that 
DHA-induced alterations in Ras PM targeting do not involve Ras-dependent signaling.  
In addition, the localization pattern of GFP-tH in LA- and OA-treated cells was 
essentially equivalent to those of GFP-labeled wild-type and oncogenic H-Ras, all 
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Figure 18.  DHA decreases PM localization of GFP-tH ere incubated 
with 50 µM OA, LA, or DHA for 24h prior to and 36-48h after transfection with pGFP-
tH.  Cells were stained with a vital dye FM 4-64 on a  and z-serial 
images of living cells expressing GFP-tH were obtained copy 36-48h 
post-transfection.  The relative amount of GFP-tH locali quantified as 
percent of total cellular GFP-tH as described in Materials and Methods.  A total of 31 
cells from 2 independent experiments were analyzed and data are presented as mean ± 
SE.  Different letters denote statistical significance at p <
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exhibiting ~60% relative PM localization.  This further demonstrates that biologically 
ert GFP-tH ideally reproduces the intracellular trafficking of its full-length 
ounterparts.  In marked contrast, there was no difference whatsoever among fatty acid 
eatments with respect to GFP-tK subcellular localization and relative PM expression 
ig. 19 and Fig. 20), similar to GFP-labeled full-length wild-type and oncogenic K-Ras.  
ch greater 
extent (69.0 ± 
e the 
apparent endom  
roteins and GFP-tK. 
DHA effects on intracellular Ras trafficking to the PM are reversible 
Next, experiments were designed to investigate whether DHA-induced changes in 
protein subcellular localization are reversible.  It was reasoned that if DHA enrichment 
in cellular membranes is involved as an underlying mechanism of action, the DHA-
in
c
tr
(F
However, differences in subcellular distribution were evident between GFP-tK and GFP-
labeled full-length K-Ras.  GFP-tK predominantly localized to the PM to a mu
± 0.8%) than GFP-Kras-wt (44.5 ± 2.3%) and GFP-KrasG12V (37.8 
0.7%), and had negligible expression at the endomembrane compartments unlik
embrane association of full-length K-Ras (Fig. 11, Fig. 15, and Fig. 19). 
These data suggest that there may be differences in the efficiency and kinetics of PM 
targeting and/or post-translational processing between full-length K-Ras GFP fusion 
p
In conclusion, the identical trends in fatty acid effects observed in cells 
expressing GFP chimeras of either wild-type, constitutively active mutants, or 
biologically non-functional targeting motifs of Ras clearly indicate that the DHA-
induced alterations in PM targeting of Ras isoforms are independent of Ras signaling. 
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Figure 20.  PM localization of GFP-tK is not altered by f ent.  YAMC 
cells were incubated with 50 µM OA, LA, or DHA for 24h prior to and 36-48h after 
transfection with pGFP-tK.  Cells were stained with a vital dye FM 4-64 on a 
microscopic stage and z-serial images of living cells expressing GFP-tK were obtained 
by confocal microscopy 36-48h post-transfection.  The t of GFP-tK 
localized at the PM was quantified as percent of total cel  described in 
Materials and Methods.  A total of 30 cells from 2 independent experiments were 
analyzed and data are presented as mean ± SE.  No signifi as observed 
among means (p > 0.16). 
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induced decrease in protein PM targeting should be reversible upon changing the cellular 
pid environment.  To test this hypothesis, GFP-tH-expressing cells were initially 
eated with DHA for 2.5 days and were subsequently washed and further incubated with 
A or OA starting at 36h post-transfection.  Upon placing DHA-pretreated cells in LA- 
or OA-supplemented medium for 24h, the DHA-induced unique subcellular distribution 
s changed to a 
more prom
shift in loca inally 
LA or OA m mbrane DHA 
e been studied with respect to their trafficking routes and 
transport mechanisms.  Lck and Fyn are members of Src family NRTKs and play key 
roles in T cell-mediated immune responses (Lowell, 2004).  Both Lck and Fyn are dually 
acylated at the N-terminus with myristate and palmitate for PM association.  Similar to 
H- and N-Ras, newly synthesized Lck initially associates with intracellular membranes 
li
tr
L
of GFP-tH, characterized by substantial endomembrane localization, wa
inent PM staining pattern similar to LA- and OA-treated cells (Fig. 21).  This 
lization pattern was particularly evident in daughter cells of the orig
transfected cells, in which membrane biogenesis and hence membrane incorporation of 
ay have actively occurred, resulting in a decrease in the me
content.  After 48h incubation with LA or OA, GFP-tH subcellular distribution in DHA-
pretreated cells was indistinguishable from those of LA- or OA-treated cells. 
 
DHA suppresses PM localization of Lck but not Fyn 
To further extend the observations on GFP-labeled Ras, it was investigated whether the 
selective modulation of PM targeting by DHA is specific to Ras isoforms or more 
broadly effective on other lipidated proteins.  Of the lipid-modified proteins localized at 
the PM, only a few hav
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where palmitoylation occurs, and subsequently traffics to the PM via the exocytic 
pathway (Bijlmakers and Marsh, 1999).  In contrast, y (within 2-4 
min) and directly to the PM after biosynthesis on solu of and Resh, 
 to inhibitors 
of vesicular transport such as brefeldin A and m disruption of 
microtubule and actin network, somewhat analogous to K-Ras trafficking (Choy et al., 
1999; van't Hof and Resh, 1997).  Endogenous Lck a  T cells have 
been shown to localize at the PM and pericentro tures, which 
colocalized with markers of late endosomes and/o work (TGN) 
(Ehrlich et al., 2002; Ley et al., 1994).  In accord with these reports, Lck-GFP was 
detected in the PM and perinuclear structures in YAM en Lck-GFP-
expressing cells were incubated with fatty acid pattern was 
indistinguishable between LA- and OA-treated cells, w ck-GFP (60.8 
± 1.0%) localized at the PM (Fig. 22 and Fig. 23)  significantly 
decreased the PM localization (44.0 ± 1.4%) by 28% acellular pool 
of Lck-GFP markedly at the perinuclear vesicular s e cytoplasm, 
compared with both LA and OA.  Fyn-GFP has been imarily at the 
PM in COS-1, COS-7, and MDCK cells (Choy et l., 2000).  In 
addition, a close association of endogenous Fyn with een observed 
in human T lymphocytes (Ley et al., 1994).  In YAMC cells, Fyn-GFP was 
predominantly expressed at the PM with very little p fatty acid-
treated cells, somewhat similar to GFP-tK (Fig. 1 erinuclear 
Fyn is targeted rapidl
ble ribosomes (van't H
d Fyn was insensitive
onensin as well as 
nd Lck-GFP in human
somal vesicular struc
r the trans-Golgi net
C cells (Fig. 22).  Wh
s, the fluorescence 
ith the majority of L
.  In contrast, DHA
and increased the intr
tructure as well as th
 shown to localize pr
al., 1999; Webb et a
 the centrosome has b
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9), although apparent p
1997).  In addition, PM targeting of newly synthesize
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Figure 23.  DHA decreases PM localization of Lck-GF  were incubated 
with 50 µM OA, LA, or DHA for 24h prior to and 36-48h after transfection with pLck-
GFP.  Cells were stained with a vital dye FM 4-64 on a e and z-serial 
images of living cells expressing Lck-GFP were obtain croscopy 36-
48h post-transfection.  The relative amount of Lck-G the PM was 
quantified as percent of total cellular Lck-GFP as described in Materials and Methods.  
A total of 30 cells from 2 independent experiments were are presented 
as mean ± SE.  Different letters denote statistical signific  
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fluorescence was occasionally observed (Fig. 24).  Similar to K-Ras-derived GFP fusion 
onstructs, subcellular localization of Fyn-GFP in DHA-treated cells was essentially 
entical with those of LA- and OA-treated cells, with the majority of fluorescence (63.4 
 1.3%) emanating from the PM (Fig. 25).  Interestingly, similar observations were 
obtained for the subcellular distribution of Lck and Fyn by other investigators using 
lls with 25 µM 
 DHA (22:6, n-
rked decrease in 
the PM loc 0)-treated cells, 
A (20:5, n-3), or 
ebb 
t al., 2000), consistent with the results in this study. 
DHA does not alter intracellular trafficking of VSVG-GFP to the PM 
To test whether DHA also suppresses the PM delivery of conventional exocytic cargo, 
the subcellular distribution of VSVG-GFP was examined at 36-48h post-transfection in 
YAMC cells treated with fatty acids at the permissive temperature, 32°C.  As
c
id
±
dietary fatty acids.  Stulnig et al. reported that incubation of Jurkat T ce
EPA (20:5, n-3), a very long-chain n-3 PUFA found in fish oil along with
3), resulted in a rather diffuse distribution of endogenous Lck with a ma
alization, compared with untreated and stearic acid (18:
although quantification of this result was not attempted (Stulnig et al., 1998).  In 
contrast, PUFA treatment with 50 µM arachidonic acid (20:4, n-6), EP
DHA (22:6, n-3) did not affect Fyn localization to the PM fraction in Cos-1 cells (W
e
These data suggest that the differential effects of DHA on protein PM targeting 
via vesicular transport-dependent versus independent pathways may be universal to 
lipidated proteins, regardless of the orientation (C- versus N-terminal modifications) and 
composition of membrane anchors used as targeting signals. 
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Figure 25.  PM localization of Fyn-GFP is not altere  treatment.  
YAMC cells were incubated with 50 µM OA, LA, or DHA for 24h prior to and 36-48h 
after transfection with pFyn-GFP.  Cells were stained with a vital dye FM 4-64 on a 
microscopic stage and z-serial images of living cells expressing Fyn-GFP were obtained 
by confocal microscopy 36-48h post-transfection.  The r of Fyn-GFP 
localized at the PM was quantified as percent of total cellu  described in 
Materials and Methods.  A total of 30 cells from 3 independent experiments were 
analyzed and data are presented as mean ± SE.  No signifi as observed 
among means (p > 0.48). 
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transmembrane protein cargo in the exocytic pathway, the thermoreversible folding 
utant ts045 VSVG protein, and its GFP chimeras have been widely used to study 
ecretory membrane transport (Hirschberg et al., 1998; Presley et al., 1997; Scales et al., 
997; Toomre et al., 1999).  As shown in Fig. 26, VSVG-GFP expression was evident at 
the PM and the cellular processes extending from the cell surface as well as at the well-
delineated  in all 
lates the PM 
targeting of e integrity of 
m
s
1
 perinuclear Golgi and numerous intracellular vesicular-like structures
fatty acid-treated YAMC cells.  There was no difference among fatty acid-treated cells 
with respect to the relative PM expression (63.9 ± 1.4%) and overall fluorescence 
distribution (Fig. 27).  These data suggest that DHA selectively modu
 lipidated cytoplasmic cargo rather than compromising th
exocytic pathway and the bulk flow of general vesicular traffic. 
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Figure 26.  Subcellular distribution of VSVG-GFP is not alte b tt i ea n ba
with 50 µM OA, LA, or DHA for 24h prior to transfection with V G C w fu r b  f a
until live cells were examined by confocal microscopy 36-48h a r ta c c f  sec n
OA-, LA-, or DHA-treated cells are shown.  Insets in each panel de r st ed a tting
nucleus and the Golgi region of the same cell.  Arrows and N mark peri e r Golgi 
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Figure 27.  PM localization of VSVG-GFP is not al acid treatment.  
YAMC cells were incubated with 50 µM OA, LA, or DHA for 24h prior to and 36-48h 
after transfection with pVSVG-GFP.  Cells were stained with a vital dye FM 4-64 on a 
microscopic stage and z-serial images of living cells SVG-GFP were 
obtained by confocal microscopy 36-48h post-transfection.  The relative amount of 
VSVG-GFP localized at the PM was quantified as perc lar VSVG-GFP 
as described in Materials and Methods.  A total of 22 cells from 2 independent 
experiments were analyzed and data are presented a  No significant 
difference was observed among means (p > 0.44). 
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CHAPTER V 
DISCUSSION 
orrect localization of lipidated cytosolic proteins to the PM is mediated by interactions 
between lipid anchors of proteins and cell membranes.  While the importance of post-
achineries has 
ent in 
the subcellular targ
study, using  
provides ev ferentially 
anner.  DHA, a dietary n-3 PUFA enriched in fish oil, selectively decreased the PM 
olic proteins, but not transmembrane 
protein cargo, seems to be affected by DHA, suggesting that the DHA-induced 
suppression of lipidated protein PM targeting is not due to alterations in the bulk flow of 
secretory vesicular traffic. 
 
C
translational protein lipidation to provide membrane anchors and targeting signals is well 
established and our understanding of protein transport mechanisms and m
substantially progressed, the potential regulatory role of the cellular lipid environm
eting of lipidated proteins has not been well appreciated.  The present 
 GFP fusion chimeras and quantitative fluorescence imaging of living cells,
idence that a membrane lipid-modifying dietary constituent can dif
modulate the intracellular trafficking of lipidated proteins to the PM in a reversible 
m
targeting of cytoplasmic lipidated protein cargo of the exocytic pathway as opposed to 
the vesicular transport-independent protein trafficking in colonic epithelial cells.  This 
DHA effect seems to be only dependent on the protein trafficking route, irrespective of 
the types of membrane anchors as well as the functional status of lipidated proteins.  In 
addition, only the PM delivery of lipidated cytos
 
  
81
Table 1. c  r t c n t P a in
 za lg iz  
Effe ts of Dieta y Fa ty A ids o  Pro ein M T rget g 
Relative PM locali tion Relative Go i local ationGFP cons M anor
e nc
oc a y ea t (  mean  SE*  mean  SE* 
Effects of DHA 
versus LA and OA) truct 
embr e 
anch  
D pende e on 
ex ytic p thwa tr tmen n) %; ± treatment (n) %; ± (
GFP-Nra p at+ esy s 
Untreated (9) 
D 0
8 
2 
 ±
U ed
(1
9 
7 
0 
↓ PM 
↑ endomembranes s-wt 
almit e 
 farn l ye LA (21) HA (2 ) 
16. ± 1.8b
21. ± 0.8a
9.3  0.7c
ntreat  (8) 
LA (19) 
DHA 9) 
12. ± 2.4b
15. ± 1.6b
23. ± 1.6a
GFP-Hra p at+ esy s D 1
8 
5 
7 (1
 
 
4 
↓ PM 
↑ endomembranes s-wt 
almit e 
 farn l ye
OA (11) 
LA (11) 
HA (1 ) 
58. ± 1.9a
59. ± 1.7a
37. ± 1.5b
OA (11) 
LA (11) 
DHA 1) 
6.8 ± 0.8b
6.5 ± 0.6b
10. ± 1.3a
GFP-Kra ly asic region+ esy  
8 
2 
5 
⎯ s-wt po b   farn l no
OA (10) 
LA (11) 
DHA (9) 
42. ± 3.5 
45. ± 4.6 
45. ± 3.5 
  
GFP-HrasG12V p at+ esy s D 2
7 
5 
9 (1
 
 
9 
↓ PM 
↑ endomembranes 
almit e 
 farn l ye
OA (10) 
LA (13) 
HA (1 ) 
62. ± 2.9a
61. ± 2.3a
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DHA 2) 
8.4 ± 0.9b
7.9 ± 1.0b
14. ± 3.1a
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7 
0 
7 
po b  
 farn l no
OA (19) 
LA (18) 
HA (2 ) 
37. ± 1.0 
38. ± 1.1 
37. ± 1.0 
  ⎯ 
GFP-tH p at+ esy s D 0
2 
1 
1 
↓ P
↑ endom ne
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OA (11) 
LA (10) 
HA (1 ) 
59. ± 1.7a
61. ± 1.8a
36. ± 1.7b
  M embra s 
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3 
4 
3 
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OA (10) 
LA (10) 
HA (1 ) 
69. ± 1.4 
67. ± 1.4 
70. ± 1.4 
  
Lck-GFP at+ itat s D 0
7 
9 
0 
↓ PM 
 endomembranes & 
cytoplasm 
myrist e 
 palm e ye
OA (10) 
LA (10) 
HA (1 ) 
60. ± 1.4a
60. ± 1.4a
44. ± 1.4b
  ↑
Fyn-GFP at+ itat  D 0
8 
3 
1 
⎯ myrist e  palm e no
OA (10) 
LA (10) 
HA (1 ) 
63. ± 2.2 
64. ± 2.2 
62. ± 2.2 
  
VSVG-GFP trans bin s 
1 
8 
6 
⎯ mem rane doma  ye
OA (7) 
LA (7) 
DHA (8) 
62. ± 2.2 
64. ± 1.3 
64. ± 3.2 
  
 
* different letters denote statistical significance a  0t p < .05 
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e advent of GFP and techniques to fluorescently probe proteins of interest has 
revo tu of prote alization traffick ich traditionally relied 
on genetic and biochemical approaches.  The advantages provided by the use of GFP 
tagging over the traditional approaches are remarkable, allowing for real-time 
mon press acellular trafficking path and kinetics, subcellular 
localization and changes in th eters in response to cellular regulation while 
pres e olog l function  distinct stability (half-life) of the cognate protein 
(Cor , 1999 ton et al., 1996; Hirschberg et al., 1998; Piston et 
al., 1999).  More importantly, the remarkable photostability of GFP and the well-defined 
stoic himeras 
hemical 
(Patterson et al., 1997).  Due to inevitable 
not 
ide dequate resolution among different membranous subcellular organelles, which 
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cell images, these palmitoylation-deficient proteins, upon subcellular fractionation, 
primarily partitioned into the soluble cytosolic fraction or only partially associated with 
the membrane fraction, leading to misinterpretation of in vivo subcellular localization 
(Cadwallader et al., 1994; Choy et al., 1999; Hancock et al., 1989; Hancock et al., 1990; 
McCabe and Berthiaume, 1999).  In the present study, the application of GFP as a real-
time fluorescent reporter in quantitative imaging allowed for detailed observation as well 
as accurate and sensitive quantification of changes in subcellular protein localization, 
which cannot be accomplished by using the conventional approaches. 
Modulation of lipidated protein localization by different dietary sources of fat has 
previously been reported by two groups, focusing on the oncogene product Ras and its 
implication in colon cancer (Collett et al., 2001; Davidson et al., 1999; Singh et al., 
1997).  In these studies using a rat colon tumor model and malignant transformed mouse 
colonocytes, dietary fish oil and its major n-3 PUFA, DHA (22:6, n-3), significantly 
decreased the membrane to cytosol ratio of Ras proteins, relative to corn oil and LA 
(18:2, n-6), a highly prevalent vegetable fat and dietary PUFA in the U.S. diet.  The 
authors correlated this with decreases in colon tumor incidence and Ras-dependent 
signaling.  In retrospect, it can be reasoned based on the findings from the present study 
that DHA-induced decreases in H- and N-Ras PM localization may have contributed to 
the previously observed reduction in Ras membrane association, which was detected 
from total cellular membrane fractions by using pan-Ras antibodies with broad reactivity 
to all Ras isoforms.  Reddy and co-workers proposed interference with post-translational 
processing of Ras proteins as the underlying mechanism for the reduced Ras membrane 
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association, based on the decrease in FTase expression in fish oil-fed rat colon (Singh et 
al., 1998).  However, animal and cell line studies conducted by Chapkin and co-workers 
demonstrated that farnesylation state of Ras as well as FTase activity and the expression 
of hydroxymethylglutaryl CoA (HMG-CoA) reductase, the rate-limiting enzyme in 
farnesylpyrophosphate biosynthesis, is unaffected in colonic epithelial cells following 
fish oil feeding or DHA treatment (Collett et al., 2001; Davidson et al., 1999).  The 
subcellular distribution of GFP-labeled H- and N-Ras in DHA-treated cells in the present 
study is consistent with the latter case since DHA increased the endomembrane 
association of Ras rather than the cytoplasm, which would not be the case for 
unfarnesylated hence soluble Ras proteins. 
The exact mechanism(s) whereby DHA suppresses the lipidated protein PM 
targeting via the exocytic pathway remains elusive.  Although this DHA effect seems 
universal to lipidated proteins traveling through the secretory pathway, it is unlikely that 
DHA alters the general secretory vesicular traffic since the PM delivery of the 
conventional transmembrane protein cargo remained unaffected by fatty acid treatment.  
However, possible explanations can be raised based on the previous and present findings 
and are discussed below. 
The role of palmitate in protein PM targeting seems to be more than just 
increasing membrane binding affinity but rather operating as an actual targeting signal 
directing proteins to the PM, as illustrated by studies with palmitoylation-defective 
mutants and inhibition of protein palmitoylation by drugs.  Farnesylated but not 
palmitoylated H- and N-Ras proteins remain stably associated with endomembranes but 
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are not targeted to the cell surface, indicating that palmitoylation is required for correct 
PM targeting (Cadwallader et al., 1994; Choy et al., 1999; Hancock et al., 1989; 
Hancock et al., 1990; Michaelson et al., 2001) and essentially identical observations 
have been reported for members of Rho family GTPases (RhoB and TC10) (Michaelson 
et al., 2001).  Similarly, removal of palmitoylation signals or inhibition of palmitoylation 
of N-terminal targeting domains of Src-related tyrosine kinases Fyn and Yes resulted in 
accumulation of myristoylated but not palmitoylated proteins at the endomembranes 
(McCabe and Berthiaume, 1999; Webb et al., 2000; Wolven et al., 1997).  Similar 
observations have also been reported for palmitoylated transmembrane proteins such as 
G protein-coupled receptors, further supporting the notion that protein palmitoylation 
may ac
 as efficient as in untreated and LA-treated cells (Collett et al., 
2001). 
t as a bona fide PM targeting signal (Blanpain et al., 2001; Tanaka et al., 1998; 
Zhu et al., 1995).  Therefore, there is a possibility that the increased endomembrane 
association of GFP-labeled H-Ras, N-Ras, and Lck concomitant with the reduced PM 
localization in DHA-treated YAMC cells may be due to the inhibition of protein 
palmitoylation by DHA.  However, three lines of evidence strongly argue against this 
possibility.  First, Ras palmitoylation in DHA-treated YAMC cells overexpressing v-H-
Ras has been shown to be
 Given that palmitoylation is the last step of Ras post-translational modification, 
requiring the prior processing of the CAAX motif including farnesylation, this further 
indicates that DHA does not compromise the overall post-translational processing of Ras 
proteins, as also evident from the lack of a DHA effect on FTase activity, HMG-CoA 
reductase expression and Ras farnesylation state (Collett et al., 2001; Davidson et al., 
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1999).  Second, Stulnig and co-workers demonstrated that treatment with EPA (20:5, n-
3), an n-3 PUFA also found in fish oil, does not alter Lck palmitoylation in Jurkat T cells 
although EPA did change the subcellular distribution of endogenous Lck, similar to the 
DHA (22:6, n-3) effect on Lck-GFP in the present study (Stulnig et al., 1998; Stulnig et 
al., 2001).  Third, although H-Ras, N-Ras, Lck, and Fyn all require palmitoylation for 
PM targeting, PM localization and subcellular distribution of Fyn-GFP was unaffected 
by DHA, unlike GFP-Nras, GFP-Hras, and Lck-GFP, indicating that the differential 
effects of DHA on the lipidated protein localization cannot be explained by the 
inhibition of protein palmitoylation.  However, there is evidence that dietary PUFAs 
including DHA may inhibit palmitoylation of certain proteins.  In contrast to the 
insensitivity of Ras and Lck palmitoylation towards PUFA treatment, palmitoylation of 
Fyn in COS-1 cells has been shown to be substantially inhibited by 55-73% following 
arachidonic acid (20:4, n-6), EPA (20:5, n-3), or DHA (22:6, n-3) treatment (Webb et 
al., 2000).  The authors postulated that Fyn became dually acylated by N-myristoylation 
and S-acylation with PUFAs because membrane binding of Fyn remained unaffected in 
this study despite the fact that myristoylated but not palmitoylated Fyn fractionates to the 
cytosol, only partially associating with the membrane fraction (Alland et al., 1994; 
McCabe and Berthiaume, 1999; Webb et al., 2000; Wolven et al., 1997).  While newly 
synthesized H-Ras, N-Ras, and Lck are palmitoylated prior to transit to the PM 
presumably early in the exocytic pathway, Fyn has been shown to be rapidly and directly 
targeted to the PM within 5 minutes after biosynthesis and proposed to be palmitoylated 
at the PM (Apolloni et al., 2000; Bijlmakers and Marsh, 1999; Choy et al., 1999; van't 
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Hof and Resh, 1997).  These observations imply that different protein palmitoyl 
transferases with distinct subcellular distributions may be responsible for palmitoylation 
of these proteins.  Indeed, several groups of investigators assigned protein palmitoyl 
transferase activities towards different proteins to the ER, the Golgi, the ER-Golgi 
intermediate compartment, or the PM (Dunphy et al., 1996; Gutierrez and Magee, 1991; 
McLaughlin and Denny, 1999; Schroeder et al., 1996; Zhao et al., 2002).  Further 
progress in the purification and characterization of different protein palmitoyl 
transferases with regard to protein and fatty acid substrate specificity, subcellular 
localization, and cellular regulation seems necessary to explain the different sensitivities 
of protein palmitoylation towards PUFAs. 
An alternative possibility concerning protein lipidation is that DHA may be 
directly acylated to proteins in place of palmitate, thereby altering the membrane binding 
properties and subcellular localization of normally palmitoylated proteins.  Although 
palmitate (16:0) is the predominant fatty acid linked to cysteine residues of proteins, it 
appears that some proteins can be S-acylated with other acyl chains with different chain 
lengths and a varying degree of unsaturation, indicative of a somewhat relaxed fatty acid 
specificity of protein acylation by thioester linkages (Bizzozero et al., 1986; Casey et al., 
1994; Fujimoto et al., 1993; Hallak et al., 1994; Muszbek and Laposata, 1993; O'Brien et 
al., 1987).  Moreover, analysis of thioester-linked fatty acids released from human 
platelet proteins revealed that the profile of protein-bound fatty acids via thioester 
linkages can be altered by exogenously supplied fatty acids (Muszbek et al., 1999).  In 
view of the heterogeneity of protein acylation, Resh and co-workers proposed that 
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protein acylation with unsaturated fatty acids may alter membrane association properties 
of proteins such as partitioning into the liquid-ordered environment of specialized PM 
microdomains (Liang et al., 2001; Lindwasser and Resh, 2002).  Consistent with this 
notion, model membrane studies using lipopeptides or purified proteins acylated in vitro 
demonstrated that proteins modified with unsaturated fatty acids are not efficiently 
targeted to the liquid-ordered domains unlike proteins with saturated counterparts 
(Moffett et al., 2000; Wang et al., 2001).  However, the biological significance and in 
vivo consequences of heterogeneous S-acylation of proteins remain under debate 
(Stulnig et al., 2001).  The extent of heterogeneous S-acylation will be ultimately 
determined by the substrate preference of protein palmitoyl transferase as well as fatty 
acyl CoA availability in the context of physiologically relevant concentrations.  As 
discussed above, the understanding of enzymology and regulation of protein palmitoyl 
transferase has been hampered by failure to successfully purify this enzyme.  
Nevertheless, several observations stand against the potential relevance of protein 
acylation with DHA to the present study.  First, the efficiency of protein acylation with 
PUFAs seems extremely low relative to palmitate even in the PUFA-enriched 
environment such as cells incubated with PUFAs (Liang et al., 2001).  More relevant to 
the present study, base hydrolysis of total proteins or purified rhodopsin from bovine 
retina, in which DHA is naturally enriched in membranes (up to 50 mol%) and the acyl 
CoA pool, revealed that retinal proteins are predominantly acylated with palmitate (65-
95%) while DHA accounts for only less than 2% of the protein-bound fatty acids 
(DeMar and Anderson, 1997; O'Brien et al., 1987; Stone et al., 1979).  Second, the fact 
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that the palmitoylation state of Ras is unaffected by DHA in YAMC cells indicates that 
proteins modified with DHA, if any, must constitute only a minor fraction, arguing that 
neither dramatic alterations in protein localization profile nor the differential effects on 
palmitoylated proteins (H-Ras, N-Ras, and Lck versus Fyn) observed in the present 
study can be accounted for by S-acylation of proteins with DHA.  More detailed 
exploration of the potential alterations in protein palmitoylation by DHA, either 
inhibition or substitution with DHA, will require further advances in the characterization 
of protein palmitoyl transferase. 
Given that alterations in protein modification can hardly provide sufficient 
explanations for the selectivity and the substantial magnitude of DHA effects, it seems 
reasonable to conclude that the unique properties of the DHA-enriched cellular lipid 
environment and lipid-lipid and lipid-protein interactions therein are primarily 
responsible for the effects of DHA on lipidated protein localization.  Accumulation of 
PM proteins in intracellular membrane compartments can result from increased 
recycling from the cell surface via endocytosis (Nichols et al., 2001; Roy et al., 2002; 
Royle and Murrell-Lagnado, 2003).  However, this retrograde vesicular transport of 
proteins from the PM seems incompatible with the selectivity (H-Ras, N-Ras, Lck versus 
K-Ras, Fyn and VSVG) of DHA effects seen in the present study.  Even after 
considering the presence of diverse endocytic pathways originating from different PM 
subdomains (Johannes and Lamaze, 2002; Nichols, 2003; Parton and Richards, 2003), 
distinct compartmentalization of these proteins within the PM does not correlate with 
their different sensitivities to DHA in terms of subcellular localization.  Of those 
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affected by DHA, while GFP-Nras-wt, GFP-tH and Lck-GFP are preferentially 
associated with lipid rafts/caveolae, GFP-H-RasG12V predominantly resides in the 
disordered bulk PM and GFP-H-Ras-wt is equally distributed in both, as established by 
earlier work using biochemical, fluorescence and electron microscopic techniques 
(Brown, 1993; Cinek and Horejsi, 1992; Matallanas et al., 2003; Niv et al., 2002; Prior et 
al., 2001; Prior et al., 2003; Stefanova et al., 1991).  Likewise, of those unaffected by 
DHA, GFP-labeled wild-type and oncogenic K-Ras, GFP-tK, and VSVG predominantly 
localize in the bulk PM, while Fyn has been shown to be concentrated in lipid rafts 
(Chen and Resh, 2001; de Vries et al., 1998; Niv et al., 2002; Prior et al., 2001; Prior et 
al., 2003; Shenoy-Scaria et al., 1992).  Therefore, no particular form of endocytic 
pathway known to date seems to be capable of distinguishing these proteins in a manner 
that would explain why DHA differentially alters their subcellular localization. 
Taking the previous and present findings together, it can be proposed that DHA-
enriched membranes do not provide an environment conducive to forward transport of 
newly synthesized lipidated proteins.  It is likely that lipidated cytoplasmic cargos are 
discriminated against in DHA-enriched secretory apparatus when it comes to sorting into 
transport vesicles or carriers in anterograde membrane traffic.  There may be subtle 
changes in the profile of heterogeneous transport vesicle/carrier populations in terms of 
lipid composition, size, curvature, and budding efficiency such that the general bulk flow 
of membranes and delivery of conventional exocytic cargos are not affected but sorting 
of lipidated cytoplasmic cargos into transport vesicles/carriers is attenuated in DHA-
enriched secretory apparatus.  Reduced PM delivery of lipidated proteins but not 
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transmembrane proteins may result from the facilitated formation of certain types of 
transport vesicles in which packaging of membrane-embedded cargo is unaffected but 
lipidated peripheral proteins are not efficiently anchored on the cytoplasmic surface.  
However, to sustain this speculation, further studies are required to establish 1) 
differential membrane binding affinities of lipid-anchored proteins as a function of 
membrane fatty acyl composition, allowing for the preferential binding to more saturated 
membranes or microdomains over DHA-enriched counterparts, 2) heterogeneous lateral 
lipid-protein organization in DHA-enriched ER and Golgi/TGN membranes allowing for 
the formation of discrete microdomains, which will subsequently give rise to 
vesicles/carriers with different cargo profiles and possibly with different budding 
efficiencies, and 3) DHA-induced alterations in the transport vesicle/carrier population 
in relation to lipid composition and lipidated protein partitioning.  The unique properties 
of DHA-enriched membranes have been well studied using both model and biological 
membranes in view of the broad health benefits of dietary fish oil and DHA (Stillwell 
and Wassall, 2003).  The presence of six cis-double bonds enables DHA to assume 
unique conformations with large cross-sectional areas per molecule and short axial 
lengths as well as exceptional flexibility of the acyl chain to bend, tilt, and back-fold 
within membrane bilayers (Feller et al., 2002; Gawrisch et al., 2003).  Consequently, 
DHA-enriched membranes have looser lipid packing characterized by lower acyl chain 
order, faster acyl chain dynamics, and increased water permeability, relative to saturated 
membranes (Eldho et al., 2003; Holte et al., 1995; Huster et al., 1997; Mitchell and 
Litman, 1998a; Mitchell and Litman, 1998b; Paddy et al., 1985; Straume and Litman, 
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1987).  Therefore, it is conceivable that the less cohesive acyl chain packing in DHA-
enriched membranes may weaken van der Waals chain-chain interactions between lipid 
anchors of proteins and membrane phospholipids, thereby lowering binding affinity of 
lipidated proteins relative to the more tightly packed saturated membranes.  In addition, 
the presence of DHA renders membranes easily deformable elastically with a much 
lower energy requirement (Koenig et al., 1997; Smaby et al., 1997), prompting 
speculation that the local concentration of DHA may influence vesicle budding 
efficiency.  Model membrane studies have also provided a conceptual basis for the 
heterogeneous lateral distribution of DHA, although direct observation in biological 
membranes has not been reported to date due to technical challenges (Stillwell et al., 
2000).  The marked steric incompatibility between disordered, bulky polyunsaturated 
acyl chains, especially DHA, and the rigid steroid moiety of cholesterol, which exhibits 
higher affinity for saturated acyl chains in membrane bilayers has led to the model of 
transient, highly dynamic microdomains (Brzustowicz et al., 2002a; Brzustowicz et al., 
2002b; Huster et al., 1998; Mitchell and Litman, 1998a; Niu and Litman, 2002; 
Pasenkiewicz-Gierula et al., 1990).  This model envisages lateral phase separation or 
molecular sorting of membrane lipids into sterol-poor/PUFA-rich and sterol-
rich/saturated fatty acid-rich microdomains to minimize the energetically less favorable 
contact between PUFA and cholesterol. 
Several lines of previous observations from biological membranes support the 
relevance of the hypothesis of attenuated anterograde transport of lipidated proteins in 
the DHA-enriched cellular lipid environment.  First, studies of photoreceptor membrane 
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biogenesis provide evidence suggesting that there exist different local concentrations of 
DHA in TGN membranes as well as distinct protein partitioning therein, allowing for 
active sorting into discrete post-Golgi vesicles en route to specific destinations.  
Polarized DHA distribution in cell membranes has been well documented in certain cell 
types naturally enriched in DHA, such as retinal rod photoreceptor cells, brain nerve 
cells, and sperm (Breckenridge et al., 1973; Connor et al., 1998; Cotman et al., 1969; 
Fleischer and Rouser, 1965; Poulos et al., 1973; Stone et al., 1979).  DHA is particularly 
concentrated (up to 60 mol%) in the specialized and functionally most active regions 
such as rod outer segments, the PM and synaptic vesicles in brain synaptic endings, and 
sperm tails relative to the remaining parts of membranes from retinal rod cells, neurons, 
and sperm heads, respectively.  In an attempt to elucidate the mechanisms responsible 
for the polarized membrane biogenesis, Rodriquez de Turco and co-workers 
demonstrated that newly synthesized docosahexaenoyl phospholipids are sequestered 
and co-transported by rhodopsin-bearing post-Golgi vesicles when they are transported 
from the ER of inner segments, where their biosynthesis takes place, to rod outer 
segments (Rodriguez de Turco et al., 1997).  Most notably, the time course analysis of 
pulse-chase labeling indicated that segregation and association of newly synthesized 
docosahexaenoyl phospholipids and rhodopsin occur on the TGN membranes prior to 
their exit and subsequent vectorial co-transport on post-Golgi vesicles to rod outer 
segments.  Second, in adrenocortical cells, in which docosapentaenoic acid (22:5, n-3) 
and DHA (22:6, n-3) only account for 6.9 and 0.1 mol% of total cellular lipids, 
respectively, distinct types of coated vesicles differing in their size, density, and notably 
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22:5 and 22:6 profile have been isolated, indicating the presence of heterogeneous 
intracellular vesicles with different DHA distribution (de Paillerets et al., 1987).  
Although the origin of these coated vesicles remains unclear, the authors suggested that 
at least one distinct type of isolated coated vesicles originated from the Golgi, based on 
the similarity in fatty acid composition.  Third, analysis of lipid composition and 
membrane molecular order of isolated small exfoliated vesicles (50-200 nm in diameter) 
from T27A leukemia cells revealed that DHA enrichment significantly mitigated or 
reversed the characteristic differences between the parent PM and shed microdomain 
vesicles (Williams et al., 1998; Williams et al., 1999).  DHA treatment increased DHA 
content by 10-fold in shed vesicles as well as the parent PM while significantly 
decreasing cholesterol content (by 65%) and molecular order measured by fluorescence 
anisotropy in exfoliated vesicles, which are normally characterized with elevated 
cholesterol content and molecular order relative to the parent PM in untreated cells.  
Given that exfoliated vesicles normally arise from non-random regions of the cell 
surface (Armstrong et al., 1988; Beaudoin and Grondin, 1991; Black, 1980; Taylor et al., 
1988; van Blitterswijk et al., 1979), these data clearly indicate that cellular lipid 
environment can influence the lipid composition and structure of vesicles formed 
therein.  Fourth, interesting effects of DHA have been observed on the localization and 
activation of regulators of vesicular traffic, ARF and phospholipase D (PLD), in human 
peripheral blood mononuclear cells (Diaz et al., 2002).  ARF, a Ras-related small 
GTPase, regulates coated vesicle biogenesis by controlling assembly of coat proteins and 
by activating its effector, PLD, which also participates in regulation of membrane traffic 
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and actin remodeling via phosphatidic acid and indirectly via phosphatidylinositol 4,5-
bisphosphate (Brown et al., 1993; Cockcroft, 2001; Roth et al., 1999).  In this study, 
DHA enrichment of cell membranes dose-dependently increased ARF membrane 
translocation and PLD activation.  More importantly, these increases only concerned the 
disordered non-raft membrane fractions, as DHA treatment displaced both ARF and 
PLD1 from rafts, which were relatively depleted in unsaturated fatty acids.  In view of 
the role of ARF and PLD in vesicle formation, these findings of increased ARF 
translocation and PLD activation only in specific regions of DHA-enriched membranes 
bear potential implications for differential vesicle budding efficiency depending on the 
local lipid composition in relation to DHA content.  Fifth, unsaturated fatty acids are 
known to promote fusion of natural membranes as well as liposomes (Ahkong et al., 
1973; Lavoie et al., 1991; Meers et al., 1988) and this has been related to the curvature 
stress provided to membranes by inverted phase-forming lipids (Ellens et al., 1989).  In 
particular, this fusogenic effect was clearly correlated with the number of double bonds 
in acyl chains and was much more pronounced with DHA (22:6, n-3) than α-linolenic 
acid (α-18:3, n-3) (Ehringer et al., 1990; Talbot et al., 1997), implying that local DHA 
concentrations in the donor and/or acceptor membranes may affect fusion rates of 
transport vesicles.  Finally, in view of the preferential association of peripheral proteins 
anchored by long, saturated acyl chains with the liquid-ordered microdomains in the PM 
(Melkonian et al., 1999; Simons and Toomre, 2000), it is conceivable that proteins are 
also heterogeneously distributed on the surface of intracellular secretory apparatus and 
related vesicles, provided that discrete subdomains exist with different local lipid 
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arrangement.  Although several lines of circumstantial evidence discussed above 
potentially supports the hypothesis that DHA-enriched membranes selectively attenuate 
the forward transport of lipidated cytosolic proteins, further work is clearly required to 
unravel the underlying mechanisms in relation to the unique lipid/protein lateral 
organization and physicochemical properties of DHA-enriched membranes. 
While attempting to quantitatively compare the effects of dietary fatty acids on 
PM localization of different lipidated proteins, interesting quantitative and qualitative 
differences in the subcellular localization were observed among Ras isoforms, regardless 
of fatty acid treatment.  GFP-labeled Ras isoforms showed remarkable differences in the 
magnitude of PM localization; while the majority of GFP-Hras-wt (~60%) localized to 
the PM at steady-state, only ~45% of GFP-Kras-wt and ~20% of GFP-Nras-wt were 
found at the PM in YAMC cells.  To the best of our knowledge, these results provide the 
first quantitative comparison of PM targeting of different Ras isoforms in living cells.  
Siddiqui and co-workers previously estimated the Kd for Ras binding to the PM in 
ascending order of H-Ras (27.7 nM), K-Ras (47.9 nM), and N-Ras (61.1 nM), using 
competition binding assays with fully processed H-, N-, and K-Ras purified from the 
baculovirus insect cell expression system and the PM-enriched fraction from NIH3T3 
cells (Siddiqui et al., 1998).  It is interesting to find the parallel order of Ras isoforms in 
the extent of the actual in vivo PM localization and the estimated in vitro binding 
affinities for the PM, even though the efficiency and kinetics of post-translational 
processing and intracellular trafficking of each isoform are not accounted for in these 
estimated Kd values.  In addition to the striking difference in the relative PM expression, 
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the extent of Golgi localization was also quite different between GFP-labeled H-Ras and 
N-Ras, despite the common trafficking route and use of palmitate as the second targeting 
signal to the PM.  Whereas the H-Ras Golgi pool (~7-8%) was considerably smaller than 
the PM-localized H-Ras fraction (~60%), the size of N-Ras Golgi pool (~15%) was 
almost comparable to the PM fraction (~20%).  In fact, it has previously been noted that 
more N-Ras than H-Ras is associated with the Golgi at an equivalent expression level, 
based on fluorescence images of GFP-labeled Ras isoforms from several groups, 
although quantification of these observations has not been attempted (Hancock, 2003).  
In the context of the role of palmitate as a PM targeting signal, it is tempting to correlate 
the different PM targeting efficiencies between N-Ras and H-Ras with the presence of 
one (N-Ras) versus two (H-Ras) palmitates or the possible differences in the efficiency 
of protein palmitoyl transferase to recognize one versus two adjacent cysteine residues.  
In addition, in light of the recent findings that Ras engages different signaling pathways 
with distinct kinetics depending on the subcellular localization (Arozarena et al., 2004; 
Bivona et al., 2003; Chiu et al., 2002; Perez de Castro et al., 2004), one can further 
speculate that the different distribution profile of H- and N-Ras at the PM and 
endomembranes may contribute, at least in part, to the basis of their distinct signaling 
functions (Ayllon and Rebollo, 2000; Perez de Castro et al., 2004; Voice et al., 1999; 
Wolfman and Wolfman, 2000).  Interestingly, functional status also seemed to affect 
subcellular distribution of GFP-labeled Ras proteins.  This was particularly apparent in 
K-Ras-derived GFP fusion constructs.  Constitutively active oncogenic K-RasG12V 
exhibited a different endomembrane staining pattern and a slightly lower level of PM 
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localization (~38%) compared with wild-type K-Ras (~45%).  Moreover, GFP-tK, which 
lacks the N-terminal catalytic domain and the linker domain of the C-terminal 
hypervariable region, showed negligible endomembrane association unlike its full-length 
counterparts and predominantly localized to the PM to a much greater extent (~69%).  In 
recent work using a series of H-Ras mutants and a combination of quantitative electron 
microscopy and lateral diffusion measurements in living cells, Hancock and co-workers 
demonstrated that in addition to the C-terminal membrane anchors, the N-terminal 
catalytic domain and its GTP loading state as well as the linker domain of the 
hypervariable region have distinct roles in regulating membrane affinity and PM 
association of H-Ras (Rotblat et al., 2004).  In the same context, the current results from 
GFP-Kras-wt, GFP-KrasG12V, and GFP-tK may reflect the potential roles of K-Ras N-
terminal catalytic domain and its GTP- and GDP-bound conformations in regulating K-
Ras subcellular localization and intracellular trafficking. 
Although further studies are required to extend the current observations of 
dietary lipid-induced differential modulation of intracellular protein trafficking, the 
findings described in the present study carry significant biological implications, 
especially considering the potential universality towards general lipidated protein 
trafficking.  Many lipidated signaling proteins play important roles and their aberrant 
function often results in serious dysregulation of cellular function.  H-Ras, N-Ras, and 
Lck, of which subcellular localization was significantly altered by DHA in the present 
study, are all essential to a variety of cellular function and adaptive responses to external 
stimuli.  However, overactivation of these proteins either by mutation, overexpression, 
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or chronic up-regulation of their upstream receptors contributes to deleterious cellular 
malfunction including oncogenesis and inflammatory diseases (Bolen and Veillette, 
1989; Bos, 1989; Campbell and Der, 2004; Kamens et al., 2001; Kim et al., 1997; Yu et 
al., 2003).  Therefore, the selective suppression of protein PM targeting by DHA may 
constitute a novel modality of the mechanisms responsible for the long appreciated 
chemoprotective and immunomodulatory effects of dietary fish oil and DHA (Rose and 
Connolly, 1999; Stulnig, 2003; Terry et al., 2003).  In addition, the differential effects of 
DHA on the PM targeting of H-Ras versus K-Ras observed herein provide a compelling 
explanation for the selective inhibition of H-Ras activation but not K-Ras, previously 
observed in DHA-treated colon cells and fish oil-fed mouse colon (Collett et al., 2001; 
Ma et al., 2004). 
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CHAPTER VI 
CONCLUSIONS 
 
A growing body of epidemiological, clinical, and experimental evidence has 
underscored the pharmacological potential beyond the nutritional value of dietary fish oil 
enriched in very long chain n-3 PUFAs such as DHA (22:6, n-3) and EPA (20:5, n-3).  
The broad health benefits of very long chain n-3 PUFAs provide significant protection 
against a variety of unrelated human afflictions including heart disease, cancer, diabetes, 
autoimmune and inflammatory disorders (Hu et al., 2003; Kris-Etherton et al., 2002; 
Rose and Connolly, 1999; Stulnig, 2003; Terry et al., 2003).  These highly pleiotropic 
positive effects of dietary fish oil and DHA have been proposed to involve alterations in 
membrane structure and function, eicosanoid metabolism, gene expression and 
formation of lipid peroxidation products, although a comprehensive understanding of the 
mechanisms of action has yet to be elucidated (Jump, 2002; Larsson et al., 2004).  The 
present study demonstrated that DHA selectively modulates the subcellular localization 
of lipidated signaling proteins depending on their transport pathway, which may be 
universally applied to other lipidated protein trafficking.  These findings may help 
develop a new paradigm to better understand the complex effects of DHA on signaling 
networks. 
 DHA (22:6, n-3) and EPA (20:5; n-3) often exhibit similar physicochemical 
properties and biological activities on many occasions and it is likely that EPA may 
exert similar effects on lipidated protein localization (Stulnig et al., 1998).  Future 
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studies are needed to determine whe tory effects are unique to very long 
chain n-3 PUFAs found in fish oi  by other dietary PUFAs such as 
rachidonic acid (20:4, n-6) and α-linolenic acid (α-18:3, n-3). 
nt. 
ther these modula
l or are also shared
a
An interesting possibility raised by the current observations is that lipidated 
proteins may exhibit different subcellular distribution profiles in various tissues, which 
contain different membrane lipid composition.  It will be interesting to compare the 
subcellular distribution of lipidated proteins in the nerve tissues and the retina, where 
DHA constitutes up to 50 mol% of total membrane phospholipids (Anderson, 1970; 
O'Brien and Sampson, 1965) with that of other tissues typically containing less than 10 
mol% of DHA (Dyerberg and Bang, 1979; Sanders et al., 1981; Tinoco et al., 1978). 
In addition, the current findings clearly indicate that subcellular localization of 
proteins with a certain trafficking pathway can be subjected to selective regulation even 
by dietary manipulation.  Although the rationale behind the presence of complicated 
transport mechanisms for lipidated proteins as opposed to the direct targeting to final 
destinations remains unknown, regulated PM targeting of a select subset of upstream 
signaling proteins may provide a means to equip cells with the flexibility to coordinate 
the arrangement of signaling translators on the cell surface.  This may allow cells to 
optimally decode, respond, and adapt to the vagaries of the ever-changing extracellular 
environme
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